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In radiation therapy, interfraction organ motion introduces a level of geometric 
uncertainty into the planning process.  Plans, which are typically based upon a single 
instance of anatomy, must be robust against daily anatomical variations.  For this 
problem, a model of the magnitude, direction, and likelihood of deformation is useful.  In 
this thesis, principal component analysis (PCA) is used to statistically model the 3D 
organ motion for 19 prostate cancer patients, each with 8-13 fractional computed 
tomography (CT) images.  Deformable image registration and the resultant 
displacement vector fields (DVFs) are used to quantify the interfraction systematic and 
random motion.  By applying the PCA technique to the random DVFs, principal modes 
of random tissue deformation were determined for each patient, and a method for 
sampling synthetic random DVFs was developed. 
 The PCA model was then extended to describe the principal modes of systematic 
and random organ motion for the population of patients.  A leave-one-out study tested 
both the systematic and random motion model’s ability to represent PCA training set 
DVFs.  The random and systematic DVF PCA models allowed the reconstruction of 
these data with absolute mean errors between 0.5-0.9 mm and 1-2 mm, respectively.  
To the best of the author’s knowledge, this study is the first successful effort to build a 
fully 3D statistical PCA model of systematic tissue deformation in a population of 
patients. 
By sampling synthetic systematic and random errors, organ occupancy maps 
were created for bony and prostate-centroid patient setup processes.  By thresholding 
these maps, PCA-based planning target volume (PTV) was created and tested against 
conventional margin recipes (van Herk for bony alignment and 5 mm fixed [3 mm 
posterior] margin for centroid alignment) in a virtual clinical trial for low-risk prostate 
cancer.  Deformably accumulated delivered dose served as a surrogate for clinical 
outcome.  For the bony landmark setup subtrial, the PCA PTV significantly (p<0.05) 
reduced D30, D20, and D5 to bladder and D50 to rectum, while increasing rectal D20 and 
D5.  For the centroid-aligned setup, the PCA PTV significantly reduced all bladder DVH 
metrics and trended to lower rectal toxicity metrics.  All PTVs covered the prostate with 
the prescription dose. 
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1. Introduction 
The goal of fractionated definitive radiotherapy is to deliver a sufficient dose to kill 
all cancerous tumor cells while minimizing the risk of toxicity to the surrounding healthy 
tissue.  Both cancerous and healthy tissues exhibit day-to-day variations in organ 
position, shape, and volume.  These changes in 3D anatomy (referred to collectively as 
organ motion in this thesis) can be classified as either intra- or interfraction motions.  
Intrafraction motion is the change in anatomy over the course of a single daily 
treatment.  Interfraction motion is the change in anatomy from day to day.  The latter 
issue will be the focus of this thesis.   
Anatomical motion and deformation introduces geometric uncertainty into the 
radiation therapy planning process.  Conventional planning involves acquiring a 3D 
computed tomography (CT) image of the patient to plan a radiation treatment.  This CT 
image only captures a “snapshot” of the patient, or how the anatomy looks at a 
particular moment in time.  Plans based on these snapshots have the potential to be 
suboptimal for treatment as any organ motion that occurs subsequent to treatment 
planning can result in target miss and/or healthy tissue overdose.   
Ideally, online planning would be used for all radiation therapy treatments.  
Online planning involves imaging the patient in the treatment position prior to each 
fraction. While the patient is waiting, the relevant anatomy would be contoured and a 
plan of the day developed and delivered based on this current anatomical instance.  
Assuming the patient remained stationary during this process, online adaptive radiation 
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therapy would eliminate any errors introduced by interfraction motion.  Although 
intrafraction motion would not be accounted for, online adaptive radiation therapy would 
be extremely useful in sites where interfraction motion dominates organ motion, such as 
the prostate and cervix.1-3  This could also be helpful in sites such as head and neck, 
where there exists a temporal dependence of interfraction motion due to patient weight 
loss and tumor regression.4-7  In prostate radiation therapy, Ghilezan8 showed that 
idealized daily online planning provided, on average, a 13% increase in the therapeutic 
ratio.  Therapeutic ratio is the ratio of tumor control to radiation-induced normal tissue 
toxicity.  Ghilezan defined therapeutic ratio as the maximum generalized equivalent 
uniform dose (gEUD) to the prostate without exceeding specified organ at risk (OAR) 
toxicity quantified in terms of gEUD.  For prostate treatment, the dose-limiting organ 
was found to be the rectum.  Additionally, the individual benefit in therapeutic ratio 
varied widely (SD=9.7%) from patient to patient.  Still, approximately one-third of the 
patients in the Ghilezan study benefited from online adaptive planning, with therapeutic 
ratio increases of at least 15%.8   
However, such idealized online planning has a number of drawbacks, including 
the amount of time needed to create the daily plan.  The patient must be imaged, the 
target and avoidance structures delineated, and an optimized plan created, all with the 
patient remaining in the treatment position.  This lengthy process can lead to 
unacceptable patient discomfort and may seriously hinder patient throughput in the 
clinic.  For these reasons, online planning is currently impractical for daily patient care.  
While improvements are being made to hasten the online planning process,9-11 
alternative methods for accounting for anatomical uncertainty must be utilized.   
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Recent advances in in-room imaging systems, such as cone beam CT (CBCT) 
and CT-on-rails, have improved target localization in radiation therapy.12,13  Imaging 
immediately before and during treatment is becoming routine and reduces patient setup 
errors.  These images are used to rigidly align the patient’s treatment anatomy with his 
or her planning anatomy by means of couch shifts and can be based on bony anatomy, 
soft tissue landmarks, or implanted markers within the tumor.  While such deterministic 
corrections can improve the therapeutic ratio, they cannot account for all sources of 
anatomical uncertainty.14  One common deterministic correction currently practiced is 
online setup to radio opaque fiducial markers implanted directly into the prostate. 
However, not all impacts of organ motion and tissue deformation can be fully accounted 
for using translational and rotational alignment, e.g., deformations of the CTV and 
changes in shape and relative position of OARs.  These residual uncertainties must be 
accounted for by other means.  Generally, this is accomplished by creating an initial 
treatment plan that is designed to be robust against daily variations in the patient’s 
anatomy.   
To create such a plan, some form of probabilistic treatment planning (PTP) is 
usually used.  PTP is the process of maximizing the likelihood that treatment objectives 
are met in situations of anatomical uncertainty.  A simple and nearly universally used 
PTP approach is the use of a margin.  The International Commission of Radiation Units 
and Measurement (ICRU) Report 50 has defined several concepts relevant to 
margins,15 the first of which is gross tumor volume (GTV).  The GTV is the extent of 
malignancy that can be determined through physical examination, imaging, or a 
combination of the two.  The CTV is the GTV plus any presumed microscopic extension 
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of the disease.  In addition to the GTV, the treatment plan must include the CTV, as the 
CTV is presumed to contain malignant cells.  In practice, this is determined by 
measuring the GTV and expanding the volume with a margin or to adjacent anatomical 
boundaries that delimit the potential spread of subclinical disease.  The final volume is 
the ICRU 50 defined planning target volume (PTV).  The PTV is a geometrical concept 
that is used to account for possible geometric uncertainties, including patient setup 
errors, beam setup errors, and organ movement and deformation.  The PTV is generally 
taken as an expansion of the CTV using some margin that is determined to ensure 
adequate coverage of the CTV, in the event of anatomical motion.   
The use of a margin to create the PTV represents a tradeoff between target 
coverage and normal tissue toxicity.  The expansion must be large enough so the PTV 
encompasses the expected range of daily anatomic presentations.  A larger margin will 
ensure the plan is more robust against tumor miss, but it may subject larger volumes of 
the OARs to unnecessarily large doses, thereby reducing the therapeutic ratio.  
Different strategies have been proposed to estimate the optimal margin, using 
knowledge of the underlying organ motion to create a PTV that encompasses a large 
percentage of possible daily anatomies.  These margin calculations are statistical in 
nature, meant to ensure a high probability of target coverage.  For this reason, this 
thesis considers margin-based planning to be the simplest of PTP techniques.  Several 
of these strategies will be discussed later in this chapter. 
More advanced PTP methods directly incorporate probabilistic criteria into the 
planning process.  Unlike traditional objective functions, which optimize on dose criteria 
for both the PTV and OARs, PTP optimizes on the likelihood of these criteria being met 
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in the presence of organ motion.  All PTP methods require a statistical organ motion 
model.  A PTP method is only as good as its underlying assumption of the magnitude, 
direction, and likelihood of different daily anatomical configurations.  The goal of this 
thesis is to develop a 3D statistical model that includes both OARs and CTVs. 
Modeling—specifically, statistical modeling of the patient’s anatomical changes—
is the most effective strategy for accounting for those errors for which deterministic 
correction is not technically feasible or cost effective.  A model of anatomical motion, as 
the term is used in this thesis, is a statistical measure of the probability of a given 
anatomical instance over the course of radiation therapy.  Here, an anatomical instance 
is represented by a voxel-by-voxel mapping between the planning anatomy and the 
daily treatment anatomy.  This mapping is characterized by a displacement vector field 
(DVF), a general measure of organ motion.  A model gives the probability of all possible 
deformed states, as described by DVFs and can provide valuable information to the 
planning process when the treatment-day anatomy cannot be easily known.  This 
information can be directly incorporated into the planning process. 
Statistical motion models can be used for any treatment site where there is organ 
motion.  Hereafter, “organ motion” will refer to any displacement or deformation 
between the patient’s treatment day anatomy and his or her planning anatomy.  The 
work presented in this thesis is mainly focused on the development of a new model and 
its potential clinical applications.  The focus is on the anatomy critical to the treatment of 
low-risk prostate cancer, specifically, the prostate, bladder, and the rectum.  This three-
organ system in the male pelvis was chosen for several reasons.  These organs move 
relative to bony anatomy, their movement is correlated with bladder and rectal filling,16,17 
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and the intrafraction motion is smaller in relation to the interfraction motion.  Britton et al. 
reported the mean interfractional motion of an implanted fiducial to be 1.76, 3.14, and 
3.78 mm in the left-right, superior-inferior, and anterior-posterior directions, respectively.  
This compares to the measured intrafraction motion of 0.45, 1.08, and 1.45 mm.2  Su et 
al. separated the inter- and intrafractional motion into its systematic and random 
components.  Their results are shown in Table 1.1  
Table 1:  Comparison of the inter- and intrafraction motion of the prostate as measured by Su et 
al.1   
  LR SI AP 
Interfraction 
Systematic Error (mm) 2.3 3.4 4.7 
Random Error (mm) 3.7 2.7 3.5 
Intrafraction 
Systematic Error (mm) 0.3 0.5 0.6 
Random Error (mm) 0.7 1.4 1.9 
Abbreviations:  LR=left/right.  SI=superior/inferior.  AP=anterior/posterior. 
 
Additionally, the treatment target (the whole prostate) has a stable (±10%) volume over 
the treatment course.17  This reduces the possibility of any time trend in the anatomy 
over the course of treatment, removing an unnecessary extra layer of complexity to any 
modeling attempt. 
This work is intended to show the clinical benefit of incorporating statistical 
motion modeling of the prostate, bladder, and rectum into the treatment planning 
process.  This could be extended to high-risk prostate cancer patients by including 
seminal vesicles and pelvic lymph nodes in the model.  Results from this work could 
also directly benefit intermediate and high-risk prostate cancer patients, as a prostate-
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only boost is a very common part of their treatment.  This work could also be adapted 
for use in focal radiation therapy.  The model could be used to identify the daily 
locations of subregions of the prostate containing a higher concentration of malignant 
cells.  This region could then be boosted to a higher dose, with the model being used to 
ensure coverage.  This model could also be extended to different treatment sites, such 
as head and neck, and pancreas. 
1.1. External beam radiation therapy of prostate cancer 
Currently, there are a number of treatment options for patients diagnosed with 
prostate cancer.  Some of the most common include watchful waiting, radical 
prostatectomy, low dose rate brachytherapy (permanent seed implant), and external 
beam radiation therapy (EBRT), or some combination thereof.  The choice and 
effectiveness of these options are highly dependent on the tumor’s T-stage and 
biological aggressiveness (conventionally measured by Gleason score and 
pretreatment prostate-specific antigen [PSA] level).  Broadly, the National 
Comprehensive Cancer Network (NCCN) classifies prostate cancer into low, 
intermediate, and high risk.18  In both low and intermediate risk prostate cancer, the 
disease must be clinically staged as prostate-confined.  A tumor falls into the high-risk 
category if it invades adjacent structures such as the seminal vesicles and pelvic lymph 
nodes.  However, very high Gleason score (>7) or pretreatment PSA with clinical 
evidence of spread outside the prostate can also qualify the patient for high-risk status.   
As this thesis is focused on low-risk prostate cancer, discussion will be limited to 
the current interventions and their outcomes in this context.  Currently, radical 
prostatectomy, brachytherapy, and EBRT all have very favorable control rates.  Ten-
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year follow-ups after 3D conformal radiation therapy (CRT) EBRT showed a 93% rate of 
freedom from biochemical failure (bNED).19  Memorial Sloan Kettering has shown that 
by using intensity-modulated radiation therapy (IMRT) to deliver a highly conformal 
escalated dose (86.4 Gy), seven-year bNED rates for low-risk prostate cancer were as 
high as 99%.20  A separate study showed comparable results between 3D CRT EBRT 
and radical prostatectomy.21  Seven- and 10-year studies for brachytherapy have shown 
a 95% and 94.1% biochemical relapse-free survival, respectively.22,23  
While each modality exhibits excellent control rates, each option has drawbacks 
and associated side effects.  Not all patients are candidates for radical prostatectomy or 
brachytherapy, as both procedures are invasive.  Both procedures are also dependent 
on the skill of the surgeon.  EBRT is noninvasive and less dependent on physician skill.  
All procedures are associated with varying degrees of short- and long-term difficulties in 
urinary and sexual function.24-26   
For EBRT, one study of 151 patients treated to 78 Gy reported grade 2 or higher 
bladder toxicities of 10% and grade 2 or higher rectal toxicities of 26%.27  Arguably, 
EBRT has the largest potential to improve toxicity rates by limiting the dose to 
surrounding OARs.  In a literature review, Staffurth reported that by using the more 
conformal approach of IMRT instead of 3D CRT, grade ≥2 gastrointestinal toxicities 
were reduced to from 20% in 3D CRT to 6% using IMRT.28  In the same review, it was 
noted that there were no significant differences in genitourinary toxicity between 3D 
CRT (median incidence of 18%) and IMRT (median incidence of 21%).  This suggests 
that there is still a need for more optimal treatment that can help spare the bladder. 
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Combining highly conformal dose delivery with better knowledge of the target 
location has the potential to further reduce toxicity.  Anatomical uncertainty requires the 
plan to target a larger volume, increasing the bladder and rectum volumes that receive 
the full prescription dose.  One hypothesis of this thesis is that a completely 3D 
statistical model of this three-organ system to accommodate targeting uncertainty due 
to residual organ motion not controlled by a daily deterministic IGRT correction will 
reduce OAR doses needed without comprising target coverage. 
1.2. Previous work on statistical management of anatomical uncertainty 
In this thesis, targeting error is defined as the linear difference between 
corresponding anatomical locations in the patient’s planning anatomy at the time of 
simulation and the patient’s anatomy at the time of treatment.  This error arises from 
various sources, including setup errors, organ displacement, and organ/soft tissue 
deformation.  Setup errors are any errors introduced by suboptimal patient positioning in 
the treatment room.  Patient positioning can be done in several ways.  Traditionally, 
patients have been positioned on the treatment table by aligning skin tattoos with in-
room lasers in conjunction with initial and weekly port films or x-rays.  With the 
widespread use of in-room imaging, further target alignment has become quite 
common.  To align on bony landmarks, x-ray projections or CBCT are used to image the 
patient, and the bones are then used to reposition the patient to match the planning 
image.  This is fairly straightforward as the skeletal structure of the patient does not 
greatly change from day to day.  In prostate cancer, is also common to align on radio 
opaque fiducial markers implanted directly into the prostate.  In-room x-rays are then 
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taken to align the patient based on these intraprostatic markers.  This technique not 
only attempts to partly correct for setup errors, but also organ displacements. 
Translational corrections are made to account for both setup errors (errors due to 
setup alone) and organ motion.  Both tattoo and bony alignment assume that the 
patient’s soft tissue is fixed in relation to the skin and bones.  This is not the case, as 
differences have been found between tattoo (with weekly portal image verification) and 
bony alignment setups.29  There have also been reported differences between bony and 
marker based setup.30-32  Fiducial marker setup has the advantage of aligning to a point 
within the target (prostate) that is to be treated, correcting for more organ motion than a 
bony-aligned setup.  Marker-based setup has some associated uncertainty: Changes in 
inter-marker distances on the order of 1.5 mm due to prostate deformation and seed 
migration have been reported.33,34  Studies have shown differences in the prostate 
surface of over 1 mm even after post marker alignment.35,36  A fiducial alignment also 
does not account for motion in the volumes surrounding the prostate,37 such as the 
OARs.  Nearly all online setup techniques use a translation-only strategy, ignoring 
rotations and deformation.  None of these methods can fully account for daily organ 
motion.  Therefore, strategies to account for the residual error must be incorporated into 
the planning. 
In prostate cancer, the most common approach for managing residual anatomical 
uncertainty is the use of a PTV margin.  Since the introduction of PTVs, different 
formulas for their associated margins have been proposed.  For prostate treatment, the 
two most well-known formulas are those constructed by Stroom38 and van Herk.39  Both 
divide the targeting error they are accounting for into systematic and random 
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components.  Systematic error is the displacement relating the patient’s planning 
anatomy to the patient’s mean anatomy.  Random error is the daily residual 
displacement around the systematic error.  Each type of error has a different effect on 
the delivered dose distribution.  Random errors are less worrisome when compared to 
systematic, as they create a blurring of the dose distribution and tend to “wash out” over 
the course of many fractions.40  Systematic errors are more serious, as they manifest as 
shifts in the cumulative dose distribution.41  Both Stroom and van Herk formulas are 
based on statistical models and are designed to meet certain CTV coverage criteria 
over the course of treatment. 
Both formulas are designed to use the statistical motion characteristics of a 
population of similar patients.  The population statistics used in their organ motion 
modeling were the standard deviation of the systematic error distribution,  , and that of 
the random error distribution,  .  In order to calculate these population statistics, 
Stroom and van Herk assumed any targeting error can be described by one systematic 
error and one random error.  Also assumed is that the prostate is a rigid body that can 
only translate, ignoring deformation. 
Both formulas were built to probabilistically ensure dose coverage.  Stroom 
designed his margin to ensure at least 95% of the prescribed dose is delivered to an 
average of 99% of the CTV for a prostate, cervix, and lung clinical plan.  To accomplish 
this, target coverage probability is computed using the inputs   and  .  This calculation 
is then coupled with an actual 3D CRT dose distribution (for prostate, the 3 field box 
technique is used) to meet the stated criteria.  This method includes translational and 
rotational errors.  The van Herk method was aimed at providing a minimum of 95% of 
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the prescribed dose to the entire CTV for 90% of patients.  To account for systematic 
errors, this method uses purely coverage-based criteria, ignoring the dose distribution.  
The dose distribution is taken into account for random errors, where a conformal dose 
distribution with a 3.2 mm beam penumbra is assumed in the commonly used 
formulation.  This method includes translational errors only. 
Both formulas take into account setup error as well as rigid tumor motion.  For 
example, in the prostate, a bony-aligned setup would include the systematic and 
random errors of the alignment as well as the systematic and random errors of the 
prostate’s movement in relation to the bony anatomy.  As alignment to intraprostatic 
fiducial markers becomes more popular, these formulas lose value.  The systematic and 
random errors become zero as the markers are assumed to move rigidly with the rest of 
the prostate.  In these instances, there is still a need for a margin to account for the 
deformations and rotations of the prostate. 
Alternative methods have been reported that account for the residual anatomical 
uncertainty after deterministic corrections.  Such methods incorporate the use of image-
guided adaptive radiation therapy (IGART).  IGART uses data from patient images to 
adapt the original treatment plan based on anatomical characteristics of the specific 
individual.  A well-documented clinical variation of IGART is Beaumont-style adaptive 
radiation therapy (ART), hereafter referred to as “Beaumont ART.”  This method, 
developed by Yan et al., estimates the patient-specific systematic error and random 
error distribution,  , based on a limited number of fractions, k , usually taken to be 5 
days.42,43  In their method, CT simulations are taken during the first k  days of treatment, 
with the CTV contoured on all images.  The images are then aligned on bony anatomy, 
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and a convex hull is created from the union of these contours.  This structure is referred 
to as the  PTVo k , and compensates for internal target motion.  During the same time, 
in-room projections are taken directly prior to treatment and compared to digitally 
reconstructed radiographs (DRRs) to find the rigid shifts of bony anatomy.  From these 
projections, systematic and random error distributions are determined as the average 
and standard deviation of the shifts, respectively, using a Kalman prediction method to 
estimate the true values from the measurements.  The setup position is then modified to 
account for the systematic error, while a margin is added to  PTVo k  to compensate for 
the random errors.  The  PTVo k  plus the margin is referred to as the clinical PTV, or 
cl-PTV.  The patient is then replanned and treated based on the derived cl-PTV.  
Beaumont ART has been shown to give a maximum dose reduction of 2% or less to the 
CTV for at least 80% of patients in IMRT cases.42  This means that dose coverage to 
the CTV is not compromised by planning using the cl-PTV derived from a small subset 
of measurements taken in the first week of treatment.   
Beaumont ART uses the relatively simple idea of a convex hull in order to model 
the possible prostate deformations specific to an individual patient.  This method takes 
into account some of the possible deformations of the prostate, but fails to account for 
the surrounding organs at risk, such as the bladder and rectum.  In addition, Beaumont 
ART gives no guidance on how to plan and treat the patient during the data 
accumulation period.  It also relies on estimating a PTV from a limited dataset.  Due to 
the small statistical sample size (5 days of images), additional estimation of the residual 
anatomical uncertainty is needed.  Beaumont ART provides little information on how the 
prostate deforms and no information on the deformations of any OARs.  A completely 
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3D statistical model of the male pelvis would provide such information.  Incorporating 
knowledge of OAR motion, target coverage, and critical structure avoidance could 
improve the therapeutic ratio.   
1.3. Deformable image registration (DIR) 
The most complete, currently available characterization of organ motion between 
two anatomic states of a given patient is deformable image registration (DIR).  DIR 
computes the transformation that maps points in a source image to their corresponding 
voxels in the target image.  The resultant DVF quantifies the net displacement of a 
tissue subvolume during the time interval between acquisitions of the two images.  As 
multiple images are acquired over the course of treatment, each new image can be 
registered to a common image.  This produces multiple measurements of the patient’s 
interfraction motion.  With enough samples, these DVFs can be used to look for 
possible patterns in tissue motion over the entire 3D volume contained in the images. 
Fundamentally, DIR is an optimization problem.  The underlying objective 
function that drives the registration ultimately determines the resultant transformation.  
DIR generally tries to determine the transformation that minimizes the intensity 
differences between the two input images, but often includes other criteria to ensure a 
realistic correspondence between the two images.  Such criteria include regularization, 
which can ensure a smooth and realistic image.  In the end, any useful data derived 
from deformable image registration are only as reliable as the DIR algorithm’s ability to 
characterize the underlying anatomical motion.   
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1.4. Principal components analysis (PCA) 
Extracting useful information from a collection of DVFs is a difficult task.  Each 
DVF is a data structure that can store 3D displacements of millions of voxels.  The data 
associated with these voxels are often highly correlated, however.  The trajectory of a 
given voxel over the course of treatment is likely to be similar to its neighboring voxels.  
This correlation can be exploited using principal component analysis (PCA) in an 
attempt to reduce the high dimensionality of the problem.  PCA is the 
eigendecomposition of the covariance matrix of the data.  Each element of the 
covariance matrix represents the covariance between two voxels, a measure of how 
these variables change together.  PCA is the eigendecomposition of this matrix, the 
mathematical equivalent of a coordinate system transformation.  The output is a basis 
set of orthogonal eigenmodes.  The first eigenmode, or most principal component, is the 
basis vector on which one can project the greatest amount of variance in the data.  The 
second-most principal component is the orthogonal vector that can account for the most 
amount of residual variance in the data, and so on.  Each eigenmode has a 
corresponding eigenvalue.  The eigenvalues are measures of how much variance in the 
data is represented by its associated eigenmode.  Eigenmodes that represent little 
variance (generally all those totaling <10%) in the original data can then be discarded, 
further reducing the dimensionality.  These eigenmodes are assumed to represent small 
and unlikely modes of motion or possible noise in the data.   
The resultant eigenmodes are a basis set for the PCA input data, meaning the 
input data can be represented as a linear combination of these eigenmodes multiplied 
by some scaling coefficient.  As the eigenmodes are orthogonal, the distributions of their 
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associated scaling coefficients are linearly independent from one another.  For the input 
data, the distribution of these coefficients is related to a normal distribution with a 
standard deviation equal to the eigenvalue associated with the eigenmode.  In the 
context of anatomical motion, the principal components are DVF-like structures that 
represent the most likely independent patterns of motion in our dataset.  Assuming the 
initial dataset adequately represents the patient’s underlying physical motion, PCA also 
has the ability to represent future deformations in the patient that are not included in the 
initial training set.  This process is as simple as finding the corresponding scaling 
coefficients for each eigenmode.  These coefficients are calculated as the dot product of 
the eigenmode and the original data.   
In this work, the potential value in PCA lies with its ability to break down male 
pelvic motion into the underlying dominant modes of motion.  PCA also computes the 
likelihood of a given deformation as the likelihood of selecting the associated scaling 
coefficients.  These measures of the magnitude, direction, and probability of motion can 
be directly incorporated into the planning process.  Larger margins can be implemented 
in areas with high likelihood of large target deformation or displacement, and greater 
efforts can be made to spare areas more likely to be occupied by deformed instances of 
OARs.  This knowledge could be used to optimize outcomes for individual patients and 
for the patient population as a whole. 
Previously, PCA characterizations of organ motion and anatomical changes have 
been used to analyze and help diagnose diseases ranging from scoliosis to 
Alzheimer’s.44,45  Less work has been done to explore the motion of the pelvic anatomy 
in the treatment of prostate cancer.  One work of note is the detailed statistical analysis 
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done by Sohn.46  In this work, PCA was used to statistically model the surface 
deformations of the three-organ system of the prostate, bladder, and rectum.  For four 
separate patients, the organ shapes were deformably registered to the average organ 
system shape, and the principal eigenmodes of deformation were calculated, related to 
the major geometrical modes of variation.  The authors found that a patient’s organ 
shapes could be reconstructed to within 1.3–2.0 mm using four principal modes.  Their 
results are of limited value to IGART applications, as they represent only surfaces of the 
three organs mentioned.  The rest of the anatomy (both inside and outside of the three 
organs) was not modeled in their study.  In addition, their analysis was patient-specific, 
and they found no correlation between modes between patients.  Patient-specific 
models have been proposed in other sites, most notably lung.47,48  In such models of the 
prostate, numerous images are needed over the course of two or three weeks to fully 
characterize the patient specific motion.  Any intervention in treatment could only be 
done after this initial data collection period. 
This data collection problem is addressed by Budiarto et al.49  Although only 
dealing with the shape of the prostate and seminal vesicles, a PCA technique was 
outlined to incorporate population data into the analysis.  Since systematic organ motion 
error is unique for each patient’s treatment, population data is necessary in order to 
model the distribution of systematic errors across a group of patients.  Using 18 
patients, each with four DVFs, to build their training dataset, Budiarto et al. were able to 
reconstruct the deformations of three patients not included in the training set, with the 
prostate and seminal vesicle boundary displacements accurate to within 1.5 mm using 
15 eigenmodes.  Budiarto et al.’s study was limited to modeling the surfaces of the 
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prostate and seminal vesicles.  Ideally, a description of the anatomy as a whole is 
desirable.  This is especially important in prostate cancer, as the bladder and rectum 
have greater magnitudes of deformation than the prostate.  In the follow-up paper, this 
population model was used to investigate the dosimetric effect of random errors.50  For 
a single prostate case, they calculated the mean and standard deviation of the dose to 
the prostate and seminal vesicles in the presence of random deformation errors.  This 
work was very limited in clinical usefulness, however.  They admittedly ignored any 
systematic deformation errors and their effect on the dose.  Additionally, their analysis 
used a single beam and incorporated only the single most dominant mode of motion 
(representing only 34.7% of the whole spectrum energy).  Their method for calculating 
the mean and standard deviation of the dose was quite computationally expensive, 
possibly limiting its direct use in the plan optimization process. 
A population model for the entire 3D pelvic anatomy, and not just one with limited 
organ shapes, would be of great benefit.  The model could be incorporated into the 
radiation therapy treatment planning process in a number of ways.  For example, if the 
model predicted a large probability of organ motion in a certain direction but very little in 
another, the model could be used to create anisotropic margins that better spared 
normal tissue and ensured greater coverage of the prostate.  Anatomical motion 
statistics could also be incorporated into PTP.  This process would use the population 
model of the anatomical uncertainty to create a plan that maximizes the probability of 
realizing tumor coverage and other treatment goals.  The model would be based on 
population data and would require no extra information of a patient other than his 
planning CT. 
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The potential danger of a population model is that it might not benefit every 
patient.  By definition, the goal of a population model in this context is to describe the 
anatomical motion for most patients; however, patients with abnormal organ motion may 
have their tumors underdosed while patients with little organ motion may have the 
normal surrounding tissue unnecessarily overdosed.  This may be resolved in an 
adaptive strategy, using a patient-specific model, to replan the patient treatment as 
more individual data (e.g., daily CBCT images) are gathered. 
1.5. Novel research contributions and acknowledgements 
The general goal of this thesis is to develop a process for statistically modeling 
3D systematic and random tissue deformation that could, in principle, be applied to any 
treatment site.  The independent contributions of the writer (Douglas J. Vile) are as 
follows.  I, Douglas, have implemented a working tool for modeling both individual and 
population organ motion, as characterized using DVFs.  This included creating a 
detailed mathematical description of these models and creating a Matlab-based 
computer code to implement the models.  In this process, I determined a solution to the 
problem of performing organ specific deformable registrations from one patient to 
another, as well as developing DVF stitching techniques to be used in this work.  These 
inter-patient registrations were used in solving the problem of transporting patient 
specific statistics to a reference anatomy.  I am responsible for all evaluation of the 
models developed in this thesis.   
With the models in place, I proposed and implemented two virtual clinical trials 
(VCTs) in order to demonstrate clinical utility.  This was done in the context of radiation 
therapy for low-risk prostate cancer.  I also worked with Huijun Xu in order to implement 
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patient-specific statistical modeling within the probabilistic treatment planning framework 
of coverage optimized planning.   
To my knowledge, this thesis presents the most complete statistical modeling of the 
pelvic anatomy for patients undergoing definitive radiation therapy for prostate cancer.  
This work includes the statistical modeling of individual patients as well as for a 
population of patients, and is the first to report a fully 3D representation of systematic 
and random error distributions of the pelvic organ motion.  A novel method for creating 
treatment planning margins is developed that is based on the population statistical 
model. 
The work in this thesis is the realization of project first proposed by Drs. Jeffrey 
Williamson, Martin Murphy, and Ramesh Ramakrishnan in a Program Project Grant 
application last submitted to the NIH (P01CA116602) in 2006. That application 
introduced the concept of using PCA to model statistical fluctuations of organ motion 
through PCA modeling of DVFs describing both random and systematic organ motion.  
Specifically, this work stems from Project 1 (Deformable Image Registration and 
Reconstruction), Project 3 (Image-guided IMRT and Brachytherapy for Pelvic Tumors), 
and Core B (Administration, Biostatistics, and Outcomes Modeling) of that research 
grant.51-53  The author of this thesis gratefully acknowledges the guidance and 
intellectual input received from Drs. Murphy, Christensen, and Williamson during the 
course of this project.  In addition, the author would like to thank Dr. Chet ford, who 
computed many of the DVFs on which this work is based upon.  Much gratitude is 
expressed to the NKI for providing the CT images used in this thesis, to Dr. Jeffrey 
Seibers for their processing, and to Dr. Elisabeth Weiss for contouring the images.  The 
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work in this thesis could not have been possible without use of research computing 
framework (RCF) tools developed at VCU and their authors.  This work specifically uses 
the DVF generator, image and contour warping, and biological dose accumulator tools.  
The author would also like to thank Ford Sleeman and Dr. Mirek Fatyga for their help 
using these tools.  Finally, the author would like to thank Dr. Nitai Mukhopadhyay of the 
VCU Department of Biostatistics for his guidance on statistical methods utilized in this 
work. 
1.6. Research aims and organization  
Chapter 2 outlines the process through which I built a statistical PCA model using 
a series of collected images for an individual patient.  The dataset and methods used in 
this entire research are described in depth.  Efforts to validate the method are 
presented, verifying that the PCA model accurately describes the underlying patient 
anatomy.  Potential uses and applications of an individual model are also discussed. 
Because little patient-specific data is available at the beginning of treatment, 
there is not enough statistical power to create a patient-specific model.  In Chapter 3, I 
address this issue by describing the construction of a population model for the male 
pelvic organ motion.  The need for a common coordinate system in which to model the 
anatomy is presented in detail.  Any modeling errors were quantified as an assessment 
of its potential use.  The constructed model was used to calculate and compare   and 
  between two different patient setups.  A bony alignment patient setup and a 
simulated fiducial marker setup was compared.  Organ occupancy diagrams were also 
calculated and compared for the two setups.  This chapter is structured to align with a 
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manuscript that is to be submitted for publication.  This manuscript is included in 
Appendix B. 
With the population model in place for both a bony and simulated fiducial-based 
patient setup, an example of incorporating it into the treatment planning process is 
outlined in Chapter 4.  This straightforward method involved using the occupancy 
diagrams created in Chapter 3 to calculate an anisotropic margin for use in the planning 
process.  This planning method was directly compared against current planning 
techniques using the virtual clinical trial (VCT) framework.  The VCT framework allowed 
for the comparison of two planning techniques on the same patient data.  Dose volume 
histogram (DVH) metrics were used for the comparison of physical dose.   
In Chapter 5, I discuss the limitations and the potential future uses of the 
methods described in this thesis.  Topics include the potential adaptive planning 
process by individualizing the patient treatment as well as extensions of the 
methodology to other sites.  This work is supplemented by two appendices.  Appendix A 
outlines the mathematical formalism of the PCA technique.  Appendix B includes the 
manuscript on the construction and validation of the population model. 
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2. 3D systematic and random targeting error and statistical modeling  
of patient-specific anatomical deformations 
2.1. Introduction 
The anatomy of a single prostate cancer patient is never the same from 
treatment day to treatment day.  The bladder and rectum fill and empty, pressing on the 
surrounding organs, causing shape deformation and displacement.  For the 
displacement, a simple rigid shift of the patient’s treatment position can prove to be a 
beneficial correction strategy.54,55  However, no rigid shift will be able to account 
completely for deformation.  Ideally, online replanning would be used to create a plan 
specifically for that day’s anatomy.  First, the patient would be set up in the treatment 
position.  An onboard 3D image would be acquired, with contouring of all organs used in 
the planning process.  Finally, a treatment plan would be created for this specific 
anatomical instance.  A prospective virtual study has shown a theoretical increase to the 
therapeutic ratio of 13%.8  This would account for interfractional organ displacement 
and deformation, but not intrafractional motion. 
For several reasons, online planning is not practical in reality.  The biggest 
hindrance is the time necessary to image, contour, and replan.  Each of these steps 
usually requires its own specialist to complete.  The physicist or therapist is responsible 
for the imaging, the physician for the contouring, the dosimetrist for the planning, and 
the physician and physicist for quality assurance (QA) checks.  This workflow under the 
time constraint of the patient on the table is not currently feasible.  Current techniques, 
such as those reported by Wu, involve modifying the workflow of online adaptive 
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planning.  In Wu’s method, a CBCT image of the patient in the treatment position is 
acquired and DIR is performed to map this treatment image to the patient’s planning 
image.  The resultant transformation is then used to deform the dose distribution from 
the original plan; the deformed dose becomes the “goal” of a new plan.  Re-optimization 
is performed in order to determine the fluence map that gives the goal dose.  Wu 
reported the time needed for the optimization process to be 2 minutes.11  While 
promising, this process is still quite lengthy, and the poor quality of CBCT images could 
cause the DIR to give a suboptimal registration.  Deterministic corrections are much 
more practical, such as repositioning the patient to align the treatment isocenter.  This 
strategy still leaves some residual deformation of the organs unaccounted for,9,10 which 
was investigated in this study.  Thus, there is a need to create an initial plan robust 
against anatomical uncertainties. 
Probabilistic treatment planning (PTP) is the process by which one tries to 
maximize the probability of specific treatment objectives in the face of a patient’s 
unknown daily anatomy to ensure that the treatment objectives are met for a large 
percentage of the daily anatomical realizations.  These treatment objectives vary greatly 
in complexity.  The simplest objective (and the one most commonly used) is an 
expansion of the CTV by a margin to create the PTV, which ensures that most 
anatomical deviations from the planning image will still be confined to this volume.  
More advanced methods, such as coverage optimized planning first presented by 
Gordon, incorporate the dose coverage probability in the face of organ motion directly 
into the optimization process.56   
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While both of these methods are built to withstand unknown day-to-day variations 
in patient anatomy, both require knowledge of the uncertainty associated with the 
patient’s underlying organ motion.  For this reason, there is value in a patient-specific 
model of anatomical deformations.  A 3D statistical motion model of the patient allows 
these probabilistic methods to create a plan robust against realistic organ motion as 
opposed to the simplistic translational estimates currently used.  The uncertainty in the 
patient’s anatomy can be analyzed, and if there are certain deformations that are more 
likely, this knowledge can be used to create a plan that is robust even with the 
anatomical uncertainty.   
In this chapter, patient-specific statistical motion models are created using 
principal components analysis.  The PCA technique has been used previously to model 
the organs of the pelvis, most notably in the work of Sohn.46  In their work, PCA was 
used to model the shapes of the prostate, bladder, and rectum.  Four eigenmodes were 
found to be sufficient to describe each of their four patient’s daily organ shapes to within 
2 mm.  While this work laid the framework for individual modeling using PCA, it was 
limited in its applications.  Their PCA models were limited to the organ shapes, ignoring 
the daily anatomical changes within and outside of the three organs analyzed.  In this 
thesis, PCA will be used to develop models for all of the patient’s anatomy using DIR of 
a series of fan-beam CT images.   
2.1.1. Systematic and random errors 
In this work, a patient-specific model was created by partitioning daily anatomical 
differences into systematic and random components.  These components are defined 
and discussed in the context of what is define as “traditional radiotherapy” in this thesis.  
 26 
 
In traditional radiotherapy, a patient comes in for a pretreatment CT.  This image is then 
used to create a desirable treatment plan that is to be used for the entirety of the 
patient’s treatment regimen.  Thus, this image is called the planning image.  This 
planning image only represents one of the many possible anatomical instances of this 
patient.  In a worst-case scenario, this anatomy can represent an unlikely instance of 
the patient’s possible anatomies, and thus introduce a systematic difference between 
the dose intended to be delivered and the dose actually delivered.  For this treatment 
methodology, one hopes that the planning image represents the patient’s average 
anatomy.  In this work, systematic error was defined as the difference between the 
patient’s planning anatomy and the patient’s mean anatomy, averaged over the course 
of treatment.  A simple 1D example of systematic error is shown graphically below in 
Figure 1.   
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Figure 1.  1D example of systematic error.  The points represent the patient’s treatment isocenter 
on each day, k.  The blue line is the patient’s average treatment position over the course of 
therapy.  The orange line is the systematic error, or the difference between the planning isocenter 
and the mean isocenter position. 
 
Determining and planning on the patient’s mean anatomy does not eliminate 
anatomical errors by itself.  The daily fluctuations between the mean anatomy and the 
daily anatomy will also alter the delivered dose distribution.  These residual differences 
are known as the patient’s random error.  The sum of the systematic and random error 
equal the displacement of the patient’s planning anatomy from the patient’s anatomy at 
the time of treatment.  Therefore, there is a single, constant systematic error for each 
patient and a different random component for each treatment day.  These errors are 
defined more rigorously in the following sections. 
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2.2. Creating the patient-specific model 
In this section, the patient dataset used throughout this thesis is outlined, as well 
as an overview of the deformable image registration (DIR) algorithm used.  The 
concepts of systematic and random error are mathematically defined, and a principal 
component analysis technique is applied to the data to create a patient-specific 3D 
statistical model. 
2.2.1. Patient dataset 
The patient dataset used in this thesis consisted of a set of serial anonymized fan 
beam CT images, , ( )i kI x , of the male pelvis for patients undergoing definitive EBRT for 
prostate cancer.  These images were obtained from the Netherlands Cancer Institute 
(NKI), where , ( )i kI x  is the image intensity at voxel x of the CT of the i
th patient acquired 
at his kth fraction.  Each of the 19N   patients ( 1, ,i N  ) had planning (k=0) and 
8, ,13iP    (median 11) fractional images ( 1, , ik P   ) acquired throughout the course 
of treatment.  There were 210 fractional images used in this study.  On each of these 
images, the prostate, bladder, and rectum were contoured by a single experienced 
radiation oncologist.  The images were initially rigidly aligned on bony anatomy.  The 
cutoff for the superior boundary of the rectum was the inferior edge of the iliosacral 
joints.  Patients were instructed to evacuate their bladder and rectum one hour prior to 
treatment.  Afterwards, they were told to drink 250 mL of water.  The staging of the 
patients and other details of treatment are given by Deurloo.57 
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2.2.2. Deformable image registration 
To quantify the differences between the anatomy of the day and the planning 
anatomy, DIR was used.  DIR is the process of determining the mapping of each voxel 
in one image (the fixed image) to its corresponding location in another image (the 
moving image).  These mappings are represented by vectors anchored at the voxel 
centers of the fixed image.  These vectors “point” to the corresponding location in the 
moving image.  For each patient in this dataset, the Eulerian transformation, 
     ,0, ,0 ii k ih x , was defined as 
            ,0 ,0 ,0, ,0 , ,0i i ii k i i k i  h x x u x   (1) 
Here,      ,0, ,0 ii k iu x  is the DVF that associated with      ,0, ,0 ii k ih x  and ,0ix  is the 
planning image coordinate system for the patient.  The transformation maps the spatial 
locations, ,0ix  in the patient’s planning image, ,0( )iI x , to the corresponding location, ,i kx , 
in his treatment position image, ,( )i kI x .   
In this work, the small deformation, inverse consistent, linear elastic (SICLE) DIR 
algorithm was used in order to compute the transformation.  Details about this algorithm 
have been published.58  SICLE calculated the initial set of DVFs used in this work using 
both grayscale and contour information.  SICLE’s objective function contains intensity 
matching, inverse consistency, and regularizing terms.  The intensity matching was 
done by minimizing the sum of squares differences of CT intensities and contour 
information.  Contours were incorporated by converting each one to a binary mask 
image.  The optimization was simultaneously done on these binary mask images as well 
as on the grayscale CT images.  The contours used in these studies were the prostate, 
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bladder, and rectum.  The algorithm simultaneously searches for both forward, 
     ,0, ,0 ii k ih x , and inverse,      ,k,0 ,k ii ig x , DVFs relating the two input images and their 
associated contour masks.  The objective function contained terms penalizing inverse 
inconsistent registrations.  Finally, a linear elastic regularizing term was also included in 
the objective function.  The transformation was parameterized using a Fourier basis, 
with the Fourier basis coefficients representing the transform parameters being actively 
optimized.  The algorithm utilized a multi-resolution approach, first by minimizing the 
objective function on a course image grid and then by iteratively refining the Fourier 
coefficients on a finer resolution.  The final DVFs spanned the whole image with voxel 
sizes of approximately 1.8x1.8x0.3 mm.   
2.2.3. Construction of the patient-specific PCA model 
A patient-specific statistical model gives the magnitude, direction, and likelihood 
of a given deformation between the patient’s anatomy at the time of planning and the 
anatomy at the time of treatment.  As each model described the organ motion for a 
particular patient, one model was constructed to describe the anatomical motion of each 
patient, i , in the dataset.  To build the models, CT images from different days were 
deformably registered to their planning image.  As each daily image was registered to 
the same planning image, each DVF shared the domain of the planning image, ,0ix .  
Together, the DVFs represented repeated measurements of how the anatomy in the 
planning image moved from day to day.  From these DVFs, a systematic error DVF 
could be easily computed for the ith patient as 
        ,0 ,0, ,0
1
1 iP
i i ii k i
kiP


 u x u x   (2) 
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for patient i  with NP  fractional images.  The random error component for each fraction 
could then be found as the residual error after correcting for the systematic error 
              ,0 ,0 ,0, ,0 , ,0i i i ii k i i k i  Δu x u x u x   (3) 
Since the systematic error was constant for the duration of treatment, an 
individual patient deformation model, hereafter referred to as the individual model, was 
based solely on random error displacement.  This work used principal component 
analysis to create a patient’s individual model.  For a more technical description of PCA, 
please refer to Appendix A.  The covariance matrix used as input to the PCA was 
constructed as follows 
                   ,0 ,0 ,0, ,0 , ,0 , ,0
1
1cov
iP T
i i i ii k i i k i i k i
kiP
  

  C Δu x Δu x Δu x   (4) 
PCA is the eigendecomposition of this covariance matrix, which determines the linearly 
independent orthonormal eigenvectors, ,i lv , and eigenvalues, ,i l , that satisfy the 
following equation 
 , , ,i i l i l i lC v v   (5) 
The eigenvalues represented the fraction of the variability in the data 
corresponding to its associated eigenvector.  The eigenvalues were sorted, with the 
largest one associated with the most principal component, ,1iv , the second highest with 
the second most principal component, ,2iv , and so forth.  The first L  eigenvectors were 
kept.  The principal components formed an orthogonal basis, which could be used to 
reconstruct the original SICLE DVF 
        ,0 , , ,0, ,0
1
L
i i l i l i ii k i
l
c

 u x v u x   (6) 
 32 
 
where ,i lc  were scaling coefficients calculated by 
      , ,0 ,, ,0i l i i li k ic  Δu x v   (7) 
2.2.4. Kernel density estimation 
The eigenvectors resulting from the PCA were linearly independent of one 
another.  This means that the probability of a given deformation was the same as the 
probability of randomly sampling the associated set of expansion coefficients to be used 
in conjunction with equation (24) in Appendix A.  Selecting appropriate expansion 
coefficients maintained the spatial correlation between the voxels while possibly 
reducing the dimensionality, if certain eigenvectors added little to describing the 
variance in the data.  For these reasons, it was desirable to be able to randomly sample 
these expansion coefficients from a probability density function (PDF).  Following the 
method of Murphy et al.,59 the calculation of these PDFs was determined using kernel 
density estimation (KDE), also called Parzen windowing.60,61  In the end, there was one 
PDF associated with each eigenvector.   
Practically, this was done by creating a histogram of the training coefficients, ,
k
i lc , 
associated with each eigenvector, 1 il L  .  In order to represent 100% of the variance 
in the daily deformations, 1iL P  .  The training coefficients were the expansion 
coefficients needed to represent the SICLE generated DVFs as a linear combination of 
the eigenmodes, ,i lv .  Each of the daily random errors could be reconstructed using the 
patient’s systematic error, a set of iL  eigenvectors, and their associated expansion 
coefficients.  The coefficients were calculated using equation (25) in Appendix A.   
 33 
 
The expansion coefficients were found for each fractional DVF and eigenmode, l , 
creating a matrix of coefficients for each patient, i .   
 
1
,1 ,1 ,1
1
, , ,
1
, , ,
i
i
i
i i i
Pk
i i i
Pk
i l i l i li
Pk
i L i L i L
c c c
c c c
c c c
         
c
 
    
 
    
 
  (8) 
The columns of the coefficient matrix, ic , represent the coefficients needed to 
reconstruct the fractional DVFs.  The rows represent the coefficients corresponding to a 
particular eigenmode.   
PDFs were calculated for each eigenmode, each using the coefficients in the 
corresponding row of ic .  In this study, a continuous Gaussian kernel was used for the 
KDE, which centered a Gaussian around each coefficient for a given eigenmode.  The 
resultant PDF was then constructed as the superposition of these Gaussians.  The 
mathematical formulation is given in Equation (9) for the l th eigenvector 
    
2
,
, 22
1
1 exp
22
i
kP
i l
i l
ki
c c
p c
bP b 
      
   (9) 
where b  is a user-adjustable bandwidth parameter.  This parameter adjusts the width of 
the Gaussian kernel used.  In this work, the parameter was calculated from a heuristic 
rule of thumb put forth by Silverman62: 
  151.06 datab N SD   (10) 
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where dataSD is the standard deviation of the training coefficients (
1
,i lc  - ,i
P
i lc ) associated 
with a particular eigenmode, l .  Using this method, one PDF was generated for each of 
the iL  principal components. 
2.2.5. Sampling coefficients from the KDE-generated PDFs 
For patient-specific random error uncertainty, sampling the expansion coefficient 
PDFs allowed for the creation of “synthetic DVFs,”      ,0,syn ,0 ii iu x , by inserting sampled 
coefficients, ,
syn
i lc , into the following equation:  
        ,0 , , ,0,syn ,0
1
iL
syn
i i l i l i ii i
l
c

 u x v u x   (11) 
The synthetic DVFs were statistically consistent with those in the training set, 
meaning that there should have been no significant difference in the spread of the 
training set vectors and the corresponding synthetic ones.  To sample each PDF, a 
rejection sampling technique was implemented in this research.  The tails of the PDFs 
were nonzero and extended to infinity.  Because of this range, the tails were cut off to 
improve the sampling efficiency.  The cutoff was made to meet the requirement that the 
function at this point was at least 0.0001 of the maximum value.  
2.2.6. Evaluation of the patient-specific PCA model 
As an initial evaluation of the patient-specific model, the original SICLE DVFs 
were reconstructed as linear combinations of eigenmodes and expansion coefficients.  
More rigorously, the statistical correlation of synthetic DVFs output from the patient-
specific PCA model with the training DVFs were confirmed.  Specifically, in this section I 
compare the distribution of voxel vectors in the training set to those synthetically 
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created.  Hypothesis testing was performed to determine any significant difference 
between the distributions. 
2.2.6.1. Evaluation of the patient-specific PCA model’s ability to reconstruct 
training DVFs 
PCA allows one to represent the original SICLE DVFs,      ,0, ,0 ii k iu x , as a linear 
combination of eigenmodes and scalar expansion coefficients.  If no eigenmodes are 
discarded ( 1i iL P  ), the PCA model should reconstruct the training data perfectly 
using equations (6) and (7).  This is the simplest check that the eigenvectors and 
expansion coefficients are being calculated correctly.  Performing this test with all 
fractional DVFs for all patients, PCA was able to reconstruct each DVF perfectly. 
2.2.6.2. Direct evaluation of individual model on voxel vectors 
The evaluation above indicates that the individual patient statistical PCA method 
was correctly calculating the eigenvectors and expansion coefficients.  This check, while 
important, does not test the KDE or PDF sampling of the PDFs.  The general flow of the 
evaluation used to check the entire modeling process is given in Figure 2.  In this 
methodology, 1000 synthetic DVFs were created using equation (11).  At this point, the 
1000 vector values were extracted from each voxel located within the prostate, bladder, 
and rectum contours as defined on the planning image.  The 11-13 corresponding 
vector values from these same voxels were then extracted from the original SICLE 
calculated DVFs.  Finally, differences in the distributions of the synthetic and calculated 
vector values were tested against the null hypothesis (p<0.05 criteria used) at each 
organ occupied voxel.  The Wilcoxon rank-sum test was used for the hypothesis testing.  
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Figure 2:  Flowchart for the evaluation of the individual PCA model.  This flowchart was used for 
all patients; it extracted the vector values at voxels within the organs of interest (prostate, 
bladder, and rectum) to be compared with those of those in the SICLE generated DVFs. 
 
For all patients, there were no significant differences in the vector distributions for 
any voxels within each patient’s planning regions of interest.  A histogram of all of the 
p-values for all voxels in the patient population is given in Figure 3.  This result was to 
be expected, as the PCA model was designed to recreate the distributions of the data 
Read in eigenvectors, systematic  
displacement, and sampled 
coefficients
Create a synthetic DVF "on the fly" by 
linear combination of eigenvectors 
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used in the input.  Although the PCA model has the ability to create unique synthetic 
deformations, these deformations are probabilistically tied to the distribution of the 
underlying measured data. 
 
 
Figure 3:  Histogram of p-values from hypothesis testing (Wilcoxon rank-sum test) of the synthetic 
and true voxel vector distributions.  No differences were found to be significant, with the minimum 
p-value equal to 0.36.   
 
For illustrative purposes, the displacement for a single voxel (located centrally 
within the prostate) was investigated in one patient.  The voxel center (in ,0ix ) was 
displaced with the SICLE DVFs,      ,0, ,0 ii k iu x , creating a distribution of points.  These 
points are the locations of that piece of tissue on each training image.  The voxel center 
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in the planning image was similarly displaced with 1000 synthetically sampled DVFs, 
     ,0,syn ,0 ii iu x , from the individual PCA model, creating its own distribution of locations 
of this voxel.  A 3D scatter plot of the displaced voxel location is shown in Figure 4.  
Assuming the individual PCA model was correctly implemented, these two distributions 
should be identical.  The distribution means and standard deviations of the two 
distributions, as well as the p-values, are given in Table 2.  The results show no 
significant differences in the distributions. 
 
Figure 4:  3D distribution of a central prostate point location after being displaced with the training 
SICLE DVFs (red) and sampled synthetic DVFs (blue).  This was done for a single sample patient. 
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Table 2: The mean and standard deviations of deformed central prostate location (cm) in the LR 
(left-right), AP (anterior-posterior), and SI (superior-inferior) directions for the SICLE DVFs 
(measured data) and the synthetically sampled DVFs (synthetic data).  The p-value calculated from 
a Wilcoxon rank-sum test is also given between the two distributions. 
Prostate LR AP SI 
Measured Data 
Average Position (cm) 23.32 23.69 14.14 
Standard Deviation (cm) 0.11 0.26 0.11 
Synthetic Data 
Average Position (cm) 23.32 23.69 14.14 
Standard Deviation (cm) 0.12 0.28 0.13 
Hypothesis  
Testing Between 
Distributions 
p-value 0.99 0.97 0.86 
 
 
These tests demonstrated the individual model’s ability to create many synthetic 
deformations taken from a distribution probabilistically tied to that of the original training 
DVFs.  These results give confidence that the KDE method implemented in this work 
created meaningful PDFs for sampling coefficients.  With these tools in hand, the 
problem of sampling synthetic deformations probabilistically tied to the training data can 
be reduced to sampling a set of expansion coefficients from their associated PDFs to be 
incorporated into equation (11). 
However, there are limitations to these tests.  The analysis above only checks 
the ability to create synthetic DVFs consistent with the measured DVFs input into the 
PCA.  This does not test PCA’s ability to correctly predict the statistics of tissue 
deformation for an individual not included in the original training set.  Although the 
model represents the training data, there is no check that the set of training data 
samples was sufficiently large enough to represent the underlying distribution of organ 
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motion.  Ideally, a study to test this would be designed as follows.  First, a PCA model 
would be created using the methods described above from a set of DVFs mapping a 
patient’s fractional anatomy to his planning anatomy.  This model would then be tested 
on its ability to represent DVFs not included in the PCA training set.  The expansion 
coefficients would be calculated using equation (7), at which point they would be 
inserted into equation (11) to calculate the PCA model approximation of the non-training 
set DVFs.  How well the model estimates the non-training set DVFs is a measure of 
how robust the model is in representing the patient’s organ motion.  This more complete 
validation was not possible in the current work, as it required larger amounts of data 
than were available.   
2.2.7. Potential applications 
2.2.7.1. Virtual clinical trials (VCTs) 
The patient-specific PCA model has the potential to be a useful tool when 
performing VCTs.  A VCT is a framework for testing a clinical hypothesis using virtual 
patient data and theoretical outcome (bio-effective) models instead of actual patients 
and clinically observed rates of control and toxicities.  This is quite useful in radiation 
therapy.  Different planning and delivery techniques can be simulated in a treatment 
planning system (TPS) on the patient’s planning image.  The resultant fluence maps 
can then used to calculate the daily dose deposition, given the patient’s different daily 
anatomies (daily images).  DVFs are used to deform the dose to the planning image, 
where the total dose over the course of treatment can be accumulated on a voxel-by-
voxel basis.  The resultant dose distributions from the various planning techniques can 
then be directly compared.  This is generally done with a temporal sequence of CT 
 41 
 
images simulating the patient’s anatomy on a given treatment day.  In practice, it is not 
common to give a patient enough CT scans to simulate an entire fractionation 
treatment.  This is where the PCA model might be of some benefit. 
Using a limited number of patient CT images with their resultant DVFs mapped to 
the planning image, the PCA model can synthetically create an infinite number of 
unique deformations that are statistically correlated to the input DVFs.  There are two 
main benefits for doing this.  First, an entire fractionation scheme of synthetic anatomies 
can be created using a smaller number of input images.  This is done by deforming the 
planning CT with the inverse of the synthetic DVFs generated with the PCA model.  This 
provides the experimenter with numerous daily anatomies and their exact 
corresponding DVFs, relating the daily image to the planning image.  Using the known 
DVF, contours can easily and accurately be propagated onto the image of the day.  
Also, the synthetic DVF can be used to accumulate dose over a fractionated treatment.  
Using the simulated forward and inverse synthetic DVFs to create the virtual data 
eliminates any registration errors that would occur by using an imperfect deformable 
image registration algorithm on “real” daily images.  Example synthetic geometries are 
given in Figure 5. 
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Axial Sagittal 
  
  
  
Figure 5:  Axial and Sagittal views of three different synthetic geometries for a single patient 
created using the individual PCA model. 
 
There are some limitations to the PCA model approach to VCTs.  The first is that 
the resultant synthetic DVFs are only as good as the underlying data used as input to 
the PCA.  If there is some component of a patient’s anatomical variation that is not 
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present in the training data, this component will also be absent from any PCA model 
derivative anatomy.  It is therefore important to utilize an adequate number of input 
DVFs in order to model the full variability of organ motion in that patient.  For this 
reason, it is also important to use the best possible DVFs as input to the PCA.  This 
study used DVFs that were generated using both grayscale matching and manually 
drawn contour coincidence to drive the registration.  The rationale was to use as much 
a priori knowledge as possible to get the most accurate transformation possible 
describing the deformation.   
Another limitation to using the PCA model is the inability to create wildly different 
anatomies.  All synthetic anatomies are created by deforming the patient’s planning 
image with a known DVF.  Because of this, only features present in the planning image 
will be present in the synthetic image.  For example, if the planning image had 
contained a large gas pocket in the rectum, this feature would be present in all synthetic 
images created by way of the PCA model.  The gas pocket may expand or shrink, but it 
will never go away completely.  This is not the reality, as the presence of bowel gas in 
patients routinely changes day-to-day.  This problem could be addressed by deforming 
the different daily images to the planning image coordinate system, creating a set of 
planning image-like images.  These images would maintain the basic anatomical 
positions, but with varying amounts of bowel gas.   
2.2.7.2. Individual model as input to probabilistic planning 
This PCA model potentially holds some value when used in conjunction with 
PTP.  All PTP methods designed to account for interfractional motion need an estimate 
of the distribution of the potential daily errors.  The PTP algorithm can only account for 
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organ motion described in its underlying measure of the patient’s anatomical 
uncertainty.  It is here that the PCA model described above would be of benefit. 
One such PTP algorithm in which the individual PCA modeling has been 
incorporated is in coverage optimized planning (COP), as first proposed by Gordon et 
al.56  The aim of COP is to build a plan robust to anatomical uncertainty using coverage 
probability.  This creates a plan where there is a high (i.e., >95%) probability that a 
structure will be covered by certain dosimetric criteria on any given day.  COP uses the 
concept of the dose coverage histogram, which is a cumulative distribution of all 
possible voxel doses in the presence of geometric uncertainties.  COP then optimizes 
on the dose coverage histogram, choosing a plan with a high probability (i.e. 95%) of 
delivering a given cumulative dose to the patient over the whole course of treatment.  In 
the initial proof-of-concept paper, a rigid prostate was assumed, with the standard 
deviation of the distribution of systematic and random errors set to 3 mm.  A shift was 
determined as the sum of two samples taken from the systematic and random normal 
distributions.  These shifts were used to calculate the coverage probability, completely 
ignoring deformation. 
To expand this concept, the work presented in this thesis was coupled with the 
research being done with COP.  Instead of rigidly translating the prostate by an 
estimated normal distribution, the PCA model was used to create a more realistic 
patient model for the coverage probability calculation.  Thus, fully 3D deformations of 
the patient’s anatomy were taken into account when optimizing the plan.  This work, of 
which the author of this thesis was a coauthor, was led by Xu and is described in a 
paper published in Medical Physics.63  In this paper, the individual model described 
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above was used to create the virtual dataset of synthetic anatomies needed to compare 
COP technique (CPCOP) to two other planning techniques.  One planning technique 
created a plan utilizing  a fixed, 5 mm uniform margin (FM) and the other utilizing an 
optimized uniform margin (CPOM).  The optimized margin was the uniform margin 
needed to ensure that the D98 was greater than or equal to the prescription dose with 
95% coverage probability (D98,95).  Utilizing the same prostate patient cohort, Xu 
compared the plans using dose coverage criteria as well as complication-free tumor 
control probability (P+).  In the plans, the prostate prescription dose was 78 Gy, with the 
seminal vesicles prescription being 66 Gy.  The two dose limiting structures were the 
bladder and the rectum, with an artificial ring structure used for IMRT optimization.  The 
results are summarized below; the reader is referred to the paper for the details of 
planning and a full analysis of the results.   
Of the three plans, CPCOP was favored in 7/19 patients, while CPOM was favored 
in 12/19 patients, with the advantages of each plan being patient specific.  The patient-
by-patient advantages are given in Table 3, taken from Xu’s paper with permission. 
  
 46 
 
Table 3:  Patient study ID, the preferred planning technique and the most representative gain with 
respect to the other two plans in terms of target dose D98,95 for the prostate CTV (CTVprostate) 
or the seminal vesicles CTV (CTVSV), normal tissue coverage Dv,5 for bladder or rectum, and 
probability of complication free control P+. ID with */ † / ‡ denotes CPCOP / CPOM / FM plan that 
fails to achieve target D98,95.   
ID Best Plan  Gain Relative to the Other Plans 
1* CPOM   CPCOP (+0.8% CTVprostate D98,95)    FM (+6.5% P+) 
2*†‡ CPOM  CPCOP (+4.0% CTVprostate D98,95)    FM (+1.3% CTVprostate D98,95) 
3* CPOM   CPCOP (+3.4% CTVprostate D98,95)    FM (+2.8% P+) 
4*‡ CPOM    CPCOP (+7.3% CTVSV D98,95)    FM (+1.0% CTVprostate D98,95) 
5* CPOM   CPCOP (+7.2% CTVSV D98,95)    FM (+11.9% P+) 
6* CPOM   CPCOP (+1.0% CTVprostate D98,95)    FM (+21.5% P+) 
7 CPCOP  CPOM  (-3.2% Rectum, D2,5)  FM (+4.2% P+) 
8* CPOM   CPCOP (+9.8% CTVSV D98,95)    FM (+0.9% P+) 
9*†‡ CPOM   CPCOP (+7.3% CTVSV D98,95)    FM (+5.0% CTVSV D98,95) 
10*†‡ CPCOP  CPOM (+1.2% CTVSV D98,95)    FM (+5.5% CTVSV D98,95) 
11‡ CPCOP  CPOM  (+5.9% P+)  FM (+1.1% CTVprostate D98,95) 
12†‡ CPCOP CPOM  (+0.8% CTVprostate D98,95)  FM (+2.4% CTVprostate D98,95) 
13 CPOM CPCOP (+2% P+)  FM (+3.1% P+) 
14 CPOM   CPCOP (-3.1% Rectum, D2,5)    FM (+3.3% P+) 
15* CPOM   CPCOP (+8.8% D98,95)    FM (+22.8% P+) 
16‡ CPCOP  CPOM  (+1.7% P+)  FM (+1.0% CTVprostate D98,95) 
17* CPOM   CPCOP (+3.9% CTVSV D98,95)    FM (+9.5% P+) 
18*†‡ CPCOP  CPOM  (+0.6% CTVprostate D98,95)  FM ((+0.8% CTVprostate D98,95) 
19 CPCOP  CPOM  (-0.6% Rectum D30,5)  FM (+6.4% P+) 
Table reprinted from Xu with permission. 
2.2.7.3. Individual PCA model as input to adaptive planning 
The patient-specific PCA model has potential application to IGART.  Without a 
sufficient number of images, it is impossible to characterize sufficiently the patient’s 
anatomical motion.  Thus, it is impossible to utilize this statistical model before that 
patient starts treatment.  However, in-room daily patient imaging (such as CBCT) is now 
commonly used for patient setup and verification.  These images may be collected 
during the first several, usually 5,  treatment fractions.  A Beaumont-style ART method 
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could be implemented by building the patient’s individual PCA model offline using these 
initial 5 daily CTs.  The PCA model could then be used to create an adaptive plan to be 
delivered for future treatments.  This could be done once, or continually throughout 
treatment, as more information about the patient’s anatomical motion becomes 
available.   
Future research is needed to test the feasibility of this method for the PCA 
model.  There are several unknowns and complicating factors that would have to be 
resolved before this is deemed a viable option.  First, CBCT images are of substantially 
worse quality when compared to the fan-beam CT images used in the planning process.  
This lack of image quality makes the initial registrations difficult.  Secondly, the number 
of images needed to estimate adequately the patient specific organ motion distribution 
requires investigation.  Using too few images could cause the PCA to miss some modes 
of motion completely.  Beaumont ART uses Kalman filtering to account for the residual 
uncertainty from using a limited number of daily images.  A similar method could be 
implemented for the patient-specific PCA model.   
2.3. Conclusion 
In this chapter, a methodology was described for creating a patient-specific 
statistical model of day-to-day random anatomical deformations.  Such models were 
built for all 19 patients in the dataset, and each model was validated by comparing the 
distribution of the vectors in the initial dataset to synthetically created vectors.  These 
models have potential applications in virtual clinical trials, probabilistic treatment 
planning, and image guided adaptive radiation therapy. 
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3. Population PCA modeling of systematic and random tissue  
displacement errors in prostate cancer 
3.1. Introduction 
In general, a patient-specific statistical model of anatomical motion is not 
possible before the start of treatment.  Several days’ worth of images are required to 
create a model that can accurately describe the magnitude and likelihood of the 
patient’s organ motion, when conventionally there is only a single planning image taken 
before treatment.  In this scenario, a population statistical model, such as one created 
using PCA, could prove beneficial.  A population model could determine the magnitude 
and likelihood of systematic and random deformations across a patient population.  A 
population model also has the potential to model residual systematic and random errors 
that remain after a deterministic correction (i.e. aligning to fiducial markers or organ 
centroid).  Currently, these residual uncertainties remain unaccounted for.  This 
knowledge can be directly incorporated into the planning process by determining the 
probability of an organ of interest occupying a given volume in the patient’s planning 
image.  
PCA has previously been applied to the population modeling problem in the work 
of Budiarto et al.49  In their paper, they created a population shape model of prostate 
and seminal vesicle random displacement.  With an 18 patient data set used to build the 
model, they were able to reconstruct the prostate/seminal vesicle shape of three 
patients not included in their training set to within 1.5 mm.  This work only modeled the 
shape of these two organs, and did not take into account the complex motions of any 
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surrounding anatomy, including the bladder and rectum.  Also, the work of Budiarto 
ignored any systematic displacements.  The work in this thesis expands on this previous 
work by including both systematic and random displacement population modeling for 
the three organ system of the prostate, bladder, and rectum.   
Population modeling is associated with a new set of challenges when compared 
to individual modeling.  As described earlier, each patient has a single systematic error, 
which relates the patient’s planning anatomy to the patient’s mean anatomy.  Each 
patient’s systematic error is unique and cannot be computed before treatment.  Thus, a 
population model of systematic tissue displacement must account for the distribution of 
all possible systematic errors.  A similar distribution of random errors can be created 
across the patient population to form a population model of random tissue 
displacement.  Both systematic and random error distributions should be considered 
when incorporating such modeling into the patient planning.   
A reference coordinate system is needed in the formulation of both systematic 
and random error population models.  Generally, PCA requires numerous 
measurements of a set of variables.  The measurements used in this thesis are the 
displacement vectors “anchored” at the voxel centers of the reference image.  The 
reference image used in the individual model was the patient’s planning image.  
However, each patient’s planning image had a unique coordinate system, which 
represents a problem when trying to pool systematic and random errors from different 
patients.  In this chapter, I propose a solution to this problem: transporting each 
patient’s individual systematic and random errors to a calculated reference anatomy.  
This is accomplished through the use of interpatient DIR.   
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With each patient’s individual statistics transported to the reference coordinate 
system, the concept of   and   (as described previously) can be extended from the 
traditional 1D formulation to 3D for both bony- and prostate centroid-aligned patient 
setups.  PCA models for both systematic and random organ motion can be created in a 
similar fashion to the models described in Chapter 2.  The detailed creation of these 
models and their validation is included in a manuscript to be submitted to Medical 
Physics, attached in Appendix B.  This chapter summarizes the work reported in this 
manuscript, referring to the Appendix for the details and specific results.   
3.2. Construction of a reference image using interpatient DIR 
In order to determine any common modes of systematic or random tissue motion 
in a population of patients, a common coordinate system is needed.  This is achieved by 
determining the transformation,    ,0 refi refh x  that maps each patient’s planning image, 
 ,0 ,iI x  to a reference image,  ref refI x .  This registration can be used to transport 
patient-specific systematic and random errors into the reference coordinate system,
refx .  Determining the interpatient transformations is a challenging task, as the 
anatomies in the two images being registered vary greatly.  Straightforward application 
of SICLE, as described in the previous chapter, failed to converge to a solution.  As a 
result, the prostate, bladder, and rectum were registered separately using contour-only 
driven registrations. 
The construction of  ref refI x  was done by registering each patient’s planning 
image to a preselected patient’s planning image using the organ-by-organ registrations.  
This preselected patient was chosen for its lack of abnormal anatomy (such as minimal 
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bowel gas, artifacts, average organ sizes) upon visual inspection.  The resultant organ-
specific DVFs were then averaged to determine the mean organ DVFs.  Next, the mean 
DVFs were used to deform their associated organ in the preselected patient’s planning 
anatomy to the mean organ shape across the patient population.  These shapes were 
then stitched together to form the reference image,  ref refI x , which was limited to the 
three pelvic organs.  At this point, each of the patient’s planning images was registered 
to  ref refI x  on an organ-by-organ basis, giving the transformations    ,0bladder refi refh x , 
   ,0prostate refi refh x , and    ,0rectum refi refh x , along with their inverses    ,0,0bladder ii refg x ,    ,0,0prostate ii refg x , 
and    ,0,0rectum ii refg x .   
3.3. Transporting patient-specific statistics to the reference coordinate system 
The patient-specific systematic (  ,0i iu x ) and random (      ,0, ,0 ii k iΔu x ) errors 
were then transported into the reference coordinate system.  This was done by treating 
the systematic and random errors as vector-valued images and deforming them using 
each of the transformations,    ,0bladder refi refh x ,    ,0prostate refi refh x , and    ,0rectum refi refh x .  To form a 
single systematic,  ,union refi refu x , or random,  ,,union refi j refΔu x , error in the reference 
coordinate system, the resultant organ-specific motion errors were stitched together 
using equations (5) and (6) in Appendix B.  This was done for two different patient 
setups, a bony-aligned setup and a prostate centroid-aligned setup.  Practically, the 
difference between the two setups was the initial alignment of the patient planning and 
fractional images.   
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3.4. Inverse consistency error 
The common coordinate system requires individual statistics from each patient to 
be mapped to the reference image.  However, for the model to be of any value, 
information gained in the reference coordinates must be mapped back to a patient’s 
local coordinate system.  Any inverse inconsistency in the interpatient transformations 
mapping to and from the reference frame will introduce an “inverse consistency error.”  
To quantify this, patient-specific systematic and random errors were mapped to the 
reference frame, and then immediately back to the patient’s local coordinate system and 
compared with the original.  The mean and standard deviations are reported in 
Appendix B (Figure 2 and Table 1).  In each organ for all patients, the mean inverse 
consistency error is less than 0.2 mm, with over 99%, 98%, and 92% of the voxel-by-
voxel inverse consistency errors less than 0.3 mm for the prostate, bladder, and rectum, 
respectively. 
3.5. Quantifying systematic and random error distributions for the population 
With each patient’s individual statistics successfully transferred to the reference 
coordinate system, a statistical characterization of patient population was derived.  This 
was done by expanding the concepts of group mean, M , systematic ( ) and random (
 ) error distributions to three dimensions.  These concepts were originally used to 
describe the organ motion and setup error at a single point (prostate centroid), which 
was taken as a surrogate for the entire prostate.  The three-dimensional formulations 
are given in Appendix B equations (8)-(10).  Maps of these values for the two prostate 
centroid and bony patient setups are given in Appendix B (Figure 3 and Figure 4).  The 
results are as expected, with the bony aligned   and   values being smaller near bony 
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edges and a centroid-aligned setup showing smaller   and  in the central portion of 
the prostate.   
3.6. Population PCA modeling of systematic and random tissue displacement 
errors 
PCA modeling was performed separately for systematic and random errors, as 
well for the two different patient setups.  The PCA formalism for this scenario is given in 
Section II.F. of Appendix B and is done in the same manner described in the previous 
chapter.  The two covariance matrices used for the systematic and random errors are of 
particular importance, given below. 
  1 1 Tsys sys sysN C D D   (12) 
  
1
1 Trand rand rand
N
i
i
P



C D D   (13) 
where sysD  and randD  are the mean subtracted data matrices of the population of 
systematic and random errors, respectively.  In total, the systematic PCA model is 
calculated from 19 systematic errors while the random PCA model is created from 210 
random errors.   
3.7. PCA modeling error 
Unlike in the previous chapter, not all eigenvectors were used in the modeling.  In 
both the systematic and random population PCA models, only the eigenvectors needed 
to represent 95% of the variance were kept.  Eleven and 33 eigenmodes were needed 
for the systematic and random population models, respectively, to represent 95% of the 
variance in the data.  Discarding some eigenmodes introduced error in reconstructing 
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the original set of systematic and random errors.  To quantify this “PCA modeling error,” 
the difference was computed between the original systematic and random errors and 
those reconstructed using the limited number of eigenvectors.  For systematic error, the 
voxel-by-voxel differences were calculated for each organ, with 96% of all organ voxels 
having modeling error less than 1 mm.  The patient-by-patient results for both 
systematic and random error are given in Figure 65 of Appendix B. 
3.8. Leave-one-out study 
The PCA models created in this chapter are only useful if they can accurately 
describe the systematic and random errors of patients not part of the original training 
set.  To test this, a leave-one-out study was conducted, where 19 different systematic 
and random error PCA models were created, each one using data from only 18 
patients.  Each model was then used to reconstruct the systematic and random errors 
from the “left out” patient.  Within each organ, the voxel-by-voxel differences between 
the reconstructed systematic and random errors were calculated, with the mean and 
standard deviations of these differences reported.  The mean voxel differences were all 
near zero, but the standard deviations were on the order of several millimeters for some 
patients, as shown in Appendix B, Figure 76.  For the patient population, the mean, 
absolute mean, and standard deviations of the modeling errors in the leave-one-out 
study are given in Appendix B, Table 3.  The leave-one-out errors were larger for the 
systematic population PCA model, suggesting a larger dataset may be necessary to 
describe adequately the systematic anatomical motion in prostate cancer patients.   
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3.9. Organ occupancy maps 
A straightforward and useful application of the population systematic and random 
PCA models is in the construction of organ occupancy maps, which give the probability 
of an organ occupying a certain voxel on any given treatment day.  To do this, synthetic 
systematic and random errors must be sampled from their respective PCA models.  The 
sampling was done using the technique outlined in the previous chapter, with KDE used 
to construct the PDFs for each eigenmode.  In this work, the sampled systematic errors 
were added to the sampled random errors to produced synthetic deformations.  These 
deformations were then used to deform the reference anatomy, representing possible 
instances of the treatment day anatomies.  Each voxel was marked with a 1 if it was 
within the synthetic anatomy, and marked with a 0 otherwise, creating a binary image.  
This process was performed 1000 times, with the binary images averaged to yield 
probability of the organ occupying a given voxel on a given day.  This was done for both 
bony- and centroid-aligned setups, and the results are given in Appendix B, Figure 87.  
The centroid alignment has greater certainty in prostate localization when compared 
with bony-aligned setup.   
3.10. Discussion 
This chapter outlines the creation of fully 3D population models of systematic and 
random organ motion in prostate cancer patients.  Patient-specific data was transported 
to the reference frame via interpatient DIR.  These interpatient registrations were a 
difficult task; large discrepancies in patient anatomies caused the SICLE algorithm to 
fail in instances where the whole CT image was used.  Alternatively, this work used a 
method where each organ was registered separately using contour information only.  
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Although this approach was feasible for the prostate, bladder, and rectum, other pelvic 
structures of interest such as the pelvic lymph nodes and seminal vesicles were not 
modeled in this work.  Using a contour-only registration also made the modeling 
dependent on SICLE’s regularization (linear-elastic constituitive law).  For this reason, it 
is possible a finite-element DIR algorithm would have been better suited to this work, as 
it can produced non-diffeomorphic DVFs with support limited to the specified organs.   
For the population modeling described in this chapter and its associated 
appendix, interpatient registrations were used to directly deform systematic and random 
displacement vector fields to and from the reference coordinate system.  This method, 
as used in this work, only represents an approximation of the true vector transport.  As 
the systematic and random displacement vectors are transported between the reference 
and patient planning images, the orientation and magnitude of these vectors must 
change as a function of the transformation from the reference to the new image space.  
Mapping vectors from the reference to the planning images should have been done 
using the pushforward, or differential of the interpatient transformation.  The 
pushforward of the transformation  ,0i refh  is denoted by  ,0i refd h  and is a 
transformation from 3 3R R .  The pushforward is a linear map from the tangent space 
in the patient’s planning image to the tangent space in the reference image, and is 
computed as the Jacobian of  ,0i refh .  In this thesis, the pushforward was ignored.  
Large differences in the results presented in this thesis due to this omission are not 
expected to be substantial, as the organ shapes, even between patients, did not vary 
greatly.  In all future work, the pushforward will be utilized to transform the systematic 
and random vectors.     
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The population models created in this chapter have several possible clinical 
applications.  One apparent application is their potential use in PTP.  The work of Xu63 
simulated random organ motion, but assumed a known patient-specific systematic error 
for each patient in their implementation of COP.  This work could be extended to include 
simulated systematic error as well, as each patient’s systematic error is unknown before 
treatment.   
A more straightforward application of the PCA population models to patient 
planning is described in the following chapter.  This method involves using the organ 
occupancy maps calculated above to create anisotropic PTVs.  The organ occupancy 
maps can be thresholded to ensure a certain level (for example, 95%) of target 
coverage.  The dosimetric impact of planning on the PCA-based PTVs for bony- and 
centroid-aligned patients will be the focus of the next chapter.  
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4. Clinical application of a population statistical model of  
prostate cancer anatomical motion 
4.1. Introduction 
The previous chapter centered on the creation and validation of systematic and 
random tissue deformation PCA statistical models for a population of male pelvic 
patients.  In this chapter, the systematic and random tissue deformation statistical 
models will be referred to jointly as the “population PCA model.”  The ultimate value of 
any such model is its ability to deliver a better radiation therapy plan to the patient.  In 
this context, a better plan is one that is more likely to improve tumor control and/or 
reduce normal tissue toxicity when compared to the current standard of practice.  In this 
work, physical doses to the CTV and OARs were used as surrogates for these 
outcomes.  There are numerous ways to apply the population PCA model clinically.  
One of the more intriguing possibilities is to incorporate it into probabilistic planning.  
Probabilistic planning could theoretically incorporate the geometrical uncertainty as 
quantified by the PCA model directly into the optimization process.  The goal would be 
to find the optimal plan to best safeguard against dosimetric errors introduced by the 
deforming anatomy. 
In this study, a simpler clinical application of the population PCA model was 
tested.  The model was used to create “smarter” margins around a patient’s prostate, as 
contoured on the planning image.  These margins were calculated from the model by 
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determining the magnitude, direction, and likelihood of a given prostate deformation.  
These margins have the ability to be anisotropic, meaning that the thickness can vary 
as a function of location on the prostate.  This allows for a more liberal margin in areas 
where a high magnitude of deformation is likely and a more conservative one in areas 
where deformation is less likely.   
This population PCA model-generated PTV was compared to a pseudo-uniform 
margin, which is typically used currently in prostate treatments.  The comparison was 
done using the VCT framework.  Two plans created from two different PTVs were 
applied to the daily anatomies of an entire fractionation scheme.  The hypothesis was 
that using anisotropic margins derived from the population PCA model would provide, 
on average, plans with an improved therapeutic ratio compared to the current standard 
of treatment.  Information from the model regarding the deformations of the bladder and 
rectum was not used in the planning process. 
4.2. Methods and materials 
4.2.1. Planning data 
The dataset used in this study was synthetically derived from the individual PCA 
model, as described in Chapter 2.  For each of the 19 NKI patients described 
previously, the DVFs mapping the fractional images to the planning images were used 
to create an individual PCA model.  Forty-three synthetic deformations were sampled 
from each model, representing unique anatomies for an entire radiation fractionation 
regimen.  The resultant DVFs were then used to deform the patient’s planning contours, 
creating a sequence of 43 synthetic prostate, bladder, and the rectal anatomies.  
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Together, these 43 synthetic anatomies represented the patient’s daily anatomies over 
a whole therapy course.  
4.2.2. VCT subtrials  
The VCT in this project had two subtrials, each comparing two arms.  The two 
arms of each subtrial comprised two setup strategies: an online bony-alignment IGRT 
technique and an online prostate centroid-alignment IGRT technique.  The centroid-
alignment method is similar to the online procedure presented by Smitsmans, in which 
the prostate rigid alignment to the planning prostate anatomy is computed from the 
grayscale values of daily CBCTs.64,65  For each setup strategy, two arms were 
compared: a plan using population PCA model-based anisotropic margin and a plan 
using a current standard planning technique.  The first subtrial tested a bony-aligned 
population PCA model-based PTV ( PTV bonePCA ) against a PTV created using the van Herk 
margin recipe ( PTVvH ).  The second subtrial tested a centroid-aligned population PCA 
model-based PTV ( PTV centPCA ) against a PTV ( PTVcl ) created with the margin used in our 
clinic at VCU.  For each subtrial and arm, an IMRT plan was created using the patient’s 
planning image.  The planning image was a real patient (not synthetically derived) 
image, with physician-drawn contours.  Dose invariance was assumed, meaning the 
dose distribution in the accelerator coordinate system for a given fluence profile does 
not vary with changes in the patient’s anatomy.66  This assumption greatly speeds up 
the computation time needed for the VCT, as the dose distribution calculated on the 
planning image was overlaid on each daily synthetic geometry.  This assumption has 
been shown to introduce dose calculation errors of <2% in IMRT plans.66  The dose was 
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then accumulated on the planning image using the known, synthetically sampled DVFs.  
DVH metrics were calculated for each patient’s synthetic treatment course, and these 
were averaged over all patients. 
The second arm for each subtrial will hereafter be referred to as the “traditional 
plan.”  The PTV for these plans was taken by using a semi-uniform margin to expand 
the physician-drawn planning GTV (which is taken to be the prostate only).  The margin 
for these plans was calculated differently for the two subtrials, each described in detail 
below.  The differences between the two are fully described in Appendix B.   
4.2.2.2. Bony-aligned traditional plan 
For the bony-aligned construction of the traditional PTV, the classic van Herk 
margin formula was used to construct a margin in the left/right, anterior/posterior, and 
superior/inferior directions.  Using manually drawn prostate contours on each bony-
aligned fractional image for each patient, the prostate centroids were computed and 
recorded.  The systematic and random errors (  and  ) of the centroid shifts were 
calculated and used as input to the van Herk formula, given below. 
 Margin 2.5 0.7     (14) 
The values for   and   are given in Table 4, as well as the margin expansion.  
These were used to create the vHPTV  in the bony-aligned subtrial of the VCT. 
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Table 4:  The calculated values for  ,  , and the van Herk margin for the NKI dataset used in this 
study.   
 LR (mm) AP (mm) SI (mm) 
  0.5 2.6 2.0 
  1.0 2.5 2.4 
van Herk Margin 2.1 8.4 6.7 
Abbreviations: LR=left/right, AP=anterior/posterior, SI=superior/inferior. 
4.2.2.2. Bony-aligned plan based on PCA model 
The population PCA models of bony-aligned patients for systematic and random 
errors were used to sample a synthetic systematic and a random error in a reference 
coordinate system.  To avoid biasing the VCT, the PCA models were created using only 
data from other patients.  For example, only systematic error DVFs from patients 2-19 
were used in the model used in the creation of the PTV bonePCA  for the first patient.  The 
sampled systematic and random errors were then added to create a synthetic 
deformation.  This deformation was transported to the patient’s local coordinate system 
using inter-patient DIR.  The synthetic deformation, now in the patient’s local coordinate 
system, was used to deform the patient’s prostate planning contour.  This deformed 
contour represented a realization of one possible instance of the patient’s daily prostate.  
This process was repeated (456 times in total) in order to create an organ occupancy 
diagram of the prostate overlaid on the planning image.  The PTV bonePCA  was taken to be 
the volume that encapsulated 95% of all possible deformations.  As coverage followed a 
Bernoulli distribution, 456 samples were calculated; this number corresponded to a 95% 
confidence interval that the target coverage would be ±2% of the intended threshold.  A 
flowchart of the bony-aligned VCT subtrial is given in Figure 6. 
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Figure 6:  Flowchart showing the VCT process for the bony-aligned subtrial. 
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4.2.2.3. Centroid-aligned traditional plan 
The second subtrial had the patient aligned daily on the prostate centroid.  The 
daily anatomies were created in the same manner as the bony setup, but with the extra 
step of the aligning the image on the prostate centroid each day.  Only translation of the 
patient was considered.   
For the centroid-aligned traditional plan, the clPTV  was chosen to be a clinically 
popular 5 mm margin expansion in all directions except posteriorly, where a 3 mm 
expansion was used in an effort to spare the rectum from unnecessary dose.  In a study 
led by Wen, the authors concluded that this margin is a good choice in IMRT plans, as 
judged by a superior complication-free tumor control probability (P+) when compared to 
margins of 10 mm/6 mm posteriorly and a 3 mm uniform margin.67 
4.2.2.4. Centroid-aligned plan based on PCA model 
The PTV centPCA  was determined in a manner very similar to that described in Section 
4.2.2.2., with the difference being in how the population PCA model was created.  The 
prostate centroid was used to align each patient’s fractional images to his planning 
image.  After this initial alignment, the DVFs associated with these two images, 
     ,0, ,0 ii k iu x , were calculated.  From this point, the patient-specific systematic and 
random errors were calculated as described in Chapter 2, and the centroid-aligned 
population PCA model was created using the methods outlined in Chapter 3.  A 
flowchart for the centroid-aligned subtrial is given in Figure 7. 
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Figure 7:  Flowchart outlining the VCT process for the centroid-aligned based subtrial. 
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4.2.3. Planning setup and objectives 
For each trial arm of each subtrial, seven 6 MV beams were used to create an 
IMRT plan.  The beam angles used were 30°, 80°, 130°, 180° (posterior), 230°, 280°, 
and 330°, with the isocenter set to the PTV centroid in the planning image.  The 
planning objective criteria (Table 5) were identical.  Each patient had a prescription 
dose to the arm-specific PTV of 86 Gy over 43 fractions.  This prescription was 
designed after the dose-escalation planning protocol of Memorial Sloan Kettering.68,69  
OAR dose volume objectives were selected to achieve the minimal dose to the OARs 
while still providing target coverage.  Universal dose objectives are impossible to 
determine for every patient, as some patients present with more favorable anatomies 
than do others.  In IMRT planning, the optimizer stops once it has met all objectives; 
however, this may not be the optimal plan, as normal tissue doses may have been able 
to be lowered beyond the planning objectives.  To solve this problem and to guide the 
optimizer to achieve maximum therapeutic ratio, the bladder and rectum included 
generalized equivalent uniform dose (gEUD) as well as conventional DVH objectives.  
gEUD is the dose, which if uniformly delivered, gives the same radiobiological effect as 
the inhomogeneous dose of interest.70,71  The equation for gEUD is as follows: 
 
1
a
a
j j
j
gEUD v D
       (15) 
where jv  is the volume of the dose volume bin with dose jD , and a  is a tissue dose-
response parameter.  For healthy tissues, a  is a positive number.  In this work, an extra 
planning objective was set for the bladder and rectum, calling for a maximum gEUD = 0 
Gy ( 4a  ).  This objective can never be achieved while still meeting PTV objectives, but 
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it is useful in driving down doses to bladder and rectum below their DVH objectives.  To 
ensure that OAR dose reduction was not achieved at the expense of PTV coverage, a 
very low weight (w= 61 10 ) was used for the gEUD objectives.  The OARs used in the 
optimization were those manually contoured on the patient’s planning image.  All 
planning and dose calculations were done using Pinnacle treatment planning system 
(v9.1, Philips Medical Systems).  The maximum number of iterations used in the 
optimization process was set to 50.  In addition to the OAR gEUD objectives, the DVH 
planning objectives in Table 5 were used for plan optimization.   
 
Table 5:  Planning objectives for use in IMRT beam optimization.   
Organ Dose Criteria 
PTV D97≥86 [constrain], D2≤90.7 [80] 
Bladder D70≤19.8 [50], D50≤38.7 [25], D30≤61.9 [25], D20≤69.7 [15], D14≤74 [15], 
D9≤79.1 [15], D2≤89.4 [15] , EUDmax=0 [a=4, w= 61 10 ] 
Rectum D50≤38.7 [50], D30≤55.5 [25], D20≤69.7 [15], D5≤74.8 [50], D2≤82.6 [50], 
Dmax=84.3 [50], EUDmax=0 [a=4, w= 61 10 ] 
Femur D1≤54.6 [10] 
Ring Structure Dmax=75.3 [1] 
All doses are in Gy, with the objective weights in brackets. 
 
4.2.4. Dose accumulation 
Dose accumulation was done using in-house bio-dose accumulator software 
within the research computing framework (RCF), described by Fatyga et al.72  For each 
patient, the dose accumulator reads in the sequence of Pinnacle computed dose 
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distributions (one for each interfraction instance of anatomy), the planning image and its 
contours, and the corresponding sequence of 43 synthetic DVFs.  These DVFs 
represent the daily anatomies of the patient throughout the whole treatment course.  
The dose (which is assumed invariant), was then mapped to the planning image by 
each DVF and accumulated for the prostate, bladder, and rectum, creating a DVH for 
each of the three organs.  The D90, D95, and D97 were reported for the prostate, and the 
D50, D30, D20, and D5 were reported for the bladder and rectum.  The differences in 
these metrics were compared between the two planning arms.  Hypothesis testing was 
performed in order to assess the significance (p<0.05) of the differences between the 
DVH metrics for each arm.  For this purpose, a paired t-test was used. 
4.3. Results 
4.3.1. bonePCAPTV  and vHPTV  comparison 
For every patient, the volume of PTV bonePCA  was smaller than its corresponding 
PTVvH .  Across all patients, there was a mean 15.7% (range 10.3 – 23.2%) reduction in 
volume size.  This reduction in volume is a promising but not definitive indicator of 
possible OAR tissue sparing, as this metric gives no information on which areas of the 
PTV were being trimmed.  A visualization of the direct comparison between the two PTV 
expansions versus location is given in Figure 8 for a sample patient.  Only one patient is 
shown, as the magnitudes and patterns are similar between all patients.  Here, a 
colormap representing the PTV margin is overlaid on the manually drawn planning 
contour of the prostate.  In the area adjacent to the bladder (anterior to the prostate), 
the PCA model yields a margin reduction compared to van Herk of 2-3 mm and smaller 
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reduction in the left and right directions.  However, a substantial (~4 mm) increase in the 
margin is suggested by the PCA model in the area adjacent to the rectum.  The 
dosimetric effect of this increased margin was investigated. 
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Orientation Distance to PTV bonePCA  Distance to PTVvH   
 
  
Beam’s eye view:  
Posterior 
 
  
Beam’s eye view:  Anterior 
 
  
Beam’s eye view:  
Superior 
Figure 8:  Distance to PTV expansion maps for a sample bony-aligned patient for three different orientations from a beam’s eye view 
perspective.  The shape is that of the physician-drawn prostate where the color represents the distance to the closest point (distance in 
mm) for the two different PTV expansions, PTV bonePCA  and PTVvH .  PTV bonePCA  offers smaller margins in all locations except against the 
rectum (top row), where they can be as large as 13 mm. 
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4.3.2. VCT results for bony setup subtrial 
The DVHs for three patients are given in Figure 9.  These three patients 
represent three possible outcomes:  one in which the PCA plan is superior, one in which 
the van Herk plan is superior, and one in which they are comparable.  In order to 
determine any possible benefit for the population of the patients, DVH metrics were 
extracted for each patient.  The means and standard deviations are presented in Table 
6.  The PCA and van Herk plans each delivered the prescription dose of at least 86 Gy 
to 97% of the prostate.  The differences in prostate dose delivery were statistically 
insignificant, suggesting that the PCA posterior margin was unnecessarily large, while 
the van Herk margin was too large in all other directions.  Across the patient population, 
the PCA plan delivered significantly less dose to the D30 ( 47.96 10p   ), D20 (
54.78 10p   ), and D5 ( 33.45 10p   ) of the bladder (mean reduction of 1.9, 2.7, and 
1.2 Gy, respectively).  For the rectum, the relationship was more complicated.  The 
rectal dose differences between the two plans were deemed significant for the D50 
( 0.0230p  ), D20 ( 57.51 10p   ), and D5 ( 68.03 10p   ).  On average, the rectum D50 
for the PCA plan was lower by 1.0 Gy, but this plan provided higher doses to the D20 
and D5 (2.6, and 2.3 Gy, respectively).  This implies that the PCA plan is less effective in 
reducing the high doses to small subvolumes of the rectum, yet it may help limit lower 
doses to larger portions of the rectum.  On a patient-by-patient basis, the DVH metrics 
investigated are plotted for the prostate, bladder, and rectum in Figure 10.  For the 
bony-aligned setup, the “better” plan is not easily determined.  Using the PCA plan 
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represents a tradeoff between lowering the dose to the bladder and giving higher dose 
to portions of the rectum.    
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a.)  
b.)  
c.)  
Figure 9:  Example DVHs for three patients in the bony-aligned VCT subtrial.  Dashed 
lines represent plans using PTVvH  while solid lines represent plans using PTV bonePCA .  
Curves are given for the prostate (green), bladder (blue), and the rectum (red).  Image a) 
represents an instance where the van Herk base plan gives a resultant plan that is better 
than the PCA based plan.  Image b) shows a plan where the plans are comparable.  Image 
c) shows an instance where the PCA plan is deemed better. 
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Table 6:  The mean and standard deviation of selected DVH metrics in the prostate, bladder and 
rectum over all 19 patients in the bony-aligned setup.  The right-hand column gives the difference 
of the mean doses.  A negative difference indicates a mean dose reduction in plans created using 
PTV bonePCA .   
 DVH Metric 
Mean PCA 
Dose (Gy) 
Mean 
Traditional 
Dose (Gy) 
Mean PCA Dose - 
Traditional Dose 
(Gy) 
p-value 
Prostate 
D97 86.7±2.1 86.3±2.9 0.4 0.130 
D95 87.4±1.6 87.1±2.3 0.3 0.408 
D90 88.1±1.2 88.0±1.6 0.1 0.532 
Bladder 
D50 26.7±15.4 27.5±15.9 -0.8 0.0881 
D30 47.9±16.7 49.8±16.9 -1.9 7.96x10-4 
D20 63.1±14.5 65.8±13.4 -2.7 4.78x10-5 
D5 85.6±3.5 86.8±2.6 -1.2 3.45x10-3 
Rectum 
D50 36.0±9.2 37.0±8.5 -1.0 0.0230 
D30 56.0±7.4 55.0±7.0 1.0 0.0604 
D20 66.8±8.5 64.2±8.1 2.6 7.51x10-5 
D5 82.6±4.6 80.3±5.7 2.3 8.03x10-6 
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a.)  
b.)  
Figure 10:  Several DVH metrics for the prostate (top), bladder (middle) and rectum 
(bottom) for the bony-aligned setup.  The PCA based plan doses are the solid dots while 
the doses from the van Herk based plan are represented with an x.  The dashed 
horizontal lines show the planning criteria used with the associated DVH metric. 
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4.3.3. 
cent
PCAPTV  and clPTV  comparison 
Similar to the bony-aligned setup, the volume of PTV centPCA  was smaller than the 
PTVcl  for every patient.  The mean reduction in volume size was 27.1% (range 20.8 – 
37.4%).  A visualization of the direct comparison between the two PTV expansions 
versus location is given in Figure 11 for a sample patient.  Also similar to the bony 
setup, the margin to create PTV centPCA  is smaller than the margin for PTVcl  in every 
direction with the exception of posteriorly (adjacent to the rectum).  This effect was not 
as pronounced, however, in this scenario.   
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Orientation Distance to PTV centPCA  Distance to PTVcl   
 
  
 
Beam’s eye view:  Posterior 
 
  
Beam’s eye view:  Anterior 
 
  
Beam’s eye view:  Superior 
Figure 11:  Distance to PTV expansion maps for a sample centroid-aligned patient for three different orientations from a beam’s eye 
view perspective.  The shape is that of the physician drawn prostate where the color represents the distance to the closest point 
(distance in mm) for the two different PTV expansions, PTV centPCA  and PTVcl . 
 78 
 
4.3.4. VCT results for centroid-aligned setup subtrial 
The DVHs for the same three patients as in the bony-aligned setup are given in 
Figure 12, this time aligned on the prostate centroid.  The population mean and 
standard deviation of selected DVH metrics are presented in Table 7.  Similar to the 
bony-aligned setup, both centroid-aligned plans delivered, on average, the prescription 
dose to 97% of the prostate.  While both provided acceptable target coverage, the PCA 
plan significantly reduced the dose on average to both the bladder and the rectum for 
the DVH metrics investigated; the lone exception was D5 to the rectum.  Here, no 
significant difference was found between the two plans.  The p-values are given in 
Table 7.  On a patient-by-patient basis, the four DVH metrics investigated are plotted for 
the prostate, bladder, and rectum in Figure 13.  
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(a.)  
(b.)  
(c.)  
Figure 12:  Example DVHs for three patients in the centroid-aligned VCT subtrial.  Dashed 
lines represent plans using PTVcl  while solid lines represent plans using PTV centPCA .  
Curves are given for the prostate (green), bladder (blue), and the rectum (red).  Image (a) 
represents an instance where the PCA based plan provides less dose coverage to the 
prostate.  Image (b) shows a plan where the plans are comparable.  Image (c) shows an 
instance where the PCA plan is deemed better. 
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Table 7:  The mean and standard deviation of selected DVH metrics in the prostate, bladder, and 
rectum over all 19 patients in the centroid-aligned setup.  The right-hand column gives the 
difference of the mean doses.  A negative difference indicates a mean dose reduction in plans 
created using PTV centPCA .   
 DVH Metric 
Mean PCA 
Dose (Gy) 
Mean 
Traditional 
Dose (Gy) 
Mean PCA Dose 
- Traditional 
Dose (Gy) 
p-value 
Prostate 
D97 87.0±1.1 87.4±1.2 -0.4 0.0956 
D95 87.4±0.9 88.0±0.8 -0.6 0.0323 
D90 88.1±0.7 88.6±0.6 -0.5 0.0117 
Bladder 
D50 20.7±13.0 24.0±12.8 -3.3 2.93x10-3 
D30 40.0±15.5 45.4±15.0 -5.4 5.81x10-4 
D20 54.8±15.1 61.6±13.5 -6.8 6.22x10-5 
D5 83.2±5.1 86.1±3.0 -2.9 1.40x10-4 
Rectum 
D50 34.0±9.7 37.5±8.3 -3.5 8.84x10-4 
D30 50.4±5.8 53.2±4.5 -2.8 1.13x10-4 
D20 59.2±6.2 61.0±4.4 -1.8 3.90x10-3 
D5 78.0±3.7 77.9±2.8 0.1 0.710 
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Figure 13:  DVH metrics for the prostate (top), bladder (middle) and rectum (bottom) for 
the centroid-aligned patient setup.  The PCA based plan doses are the solid dots while 
the doses from the 3/5mm plan are represented with an x.  The dashed horizontal lines 
show the planning criteria used with the associated DVH metric. 
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4.4. Discussion 
Results from the centroid-aligned VCT subtrial show that the PCA margin plan 
provides adequate prostate dose coverage while reducing the dose to the bladder and 
rectum for most (>75%) of the patients when compared to the plan based on the 5/3 
mm margin.  Importantly, applying the population PCA model to create a patient’s PTV 
provides a systematic and reasoned method to determine margins for prostate contour-
aligned patients.  While the formulas of Stroom and van Herk provide this function for 
bony-aligned setup, their formulas cannot be applied to the centroid-aligned case.  In 
clinical practice, the margins currently used for this patient population are created 
somewhat arbitrarily and vary widely between clinics.  The method described in this 
thesis could potentially standardize the practice for margin creation across clinics.   
While the results of the VCT were promising for the PCA-based plan in centroid-
aligned patients, they were less so for patients aligned to bony anatomy.  The PTV bonePCA  
was a smaller volume than PTVvH , yet the PCA-based plan offered a modest but 
significant dose reduction for the bladder, while raising the dose to parts of the rectum.  
In the bony-aligned trial, the PCA based plan resulted in a higher D5 in the rectum for all 
patients.  This result is unsurprising, as the PCA model of bony-aligned patients 
requires a large (up to 13 mm) margin at the prostate/rectum interface, compared to the 
8.4 mm margin computed from the van Herk formula.  This difference in margin size did 
not compromise the CTV coverage, suggesting that the 95% coverage goal of the PCA 
margin is too strict.  Future work will investigate the dosimetric effect of the more 
modest coverage goals of 90% and 80%.  Another possible explanation for the posterior 
margin difference is that the van Herk formula indicates one margin for the posterior and 
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anterior directions.  The PCA model shows the prostate having larger and more varying 
shifts posteriorly.  An example of this variability at the rectum is shown in Figure 14.  
The pubic symphysis is anterior to the prostate, limiting the amount of motion allowed in 
that direction.  The lack a motion in the anterior direction may reduce the formula-
suggested margin in both the anterior and posterior directions.  This would also explain 
why the PCA margin is smaller than the van Herk margin in the anterior direction.   
 
 
Figure 14:  An example of the prostate’s variability near the rectum interface for bony-aligned 
data.  The planning contours for the prostate and rectum are shown in red while the yellow lines 
are the physician drawn contours on a treatment day.  On this day, the rectum seems to be 
pushing the prostate against the pubic symphysis.   
 
This VCT represents a straightforward and simple approach to applying statistical 
modeling to the clinical process.  The only criterion used to create the PTV was the 95% 
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probability of encompassing the prostate.  Stroom and van Herk both used dose to the 
prostate as their final endpoint.  It is possible that the margins could be further reduced 
if the dose falloff is taken into consideration.  The work of Gordon et al. showed that the 
van Herk formula overestimated the necessary margin73 and that this was due to the 
formula’s assumption of a perfectly conformal target dose.74  The validity of the PCA 
margin developed in this work similarly suffers from not accounting for the dose falloff.   
In this VCT, information from the PCA model on the motion of the bladder and 
rectum was ignored.  A similar method of thresholding the prostate occupancy diagram 
could be extended to the OARs to create a planning organ at risk volume (PRV).  Due 
to the large amounts of deformation in the bladder and rectum, the 95% occupancy 
diagram will potentially create large PRVs, which could be unwieldy in the planning 
process.  Further research must be done to determine a sufficient thresholding 
percentage.  Planning objectives may also have to be updated to account for the larger 
planning volumes. 
4.5. Conclusion 
For two different modes of IGRT daily online setup, the VCT framework was used 
to compare the dosimetric differences between a PTV computed from a statistical model 
and a PTV commonly used in current clinical practice.  For bony-aligned setup, there 
was no clear better method between the PCA- and van Herk-based plans for the 19 
patients.  For centroid-aligned setup, the PCA plan provided proper dose coverage to 
the prostate while reducing the dose to the bladder and rectum in most patients when 
compared with a semi-uniform margin of 5 mm (3 mm posteriorly). 
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5. Conclusion 
5.1. Patient-specific PCA modeling 
Chapter 2 outlined the use of the PCA technique in modeling the patient-specific 
random errors of patients undergoing fractionated definitive radiation therapy.  By using 
the SICLE DIR algorithm, deformations over the entire image volume were modeled.  
Previously, only the shapes of select organs (prostate, bladder, and rectum) had been 
modeled.  Use of PCA technique allows the patient’s random error to be represented by 
a linear combination of eigenmodes and expansion coefficients.  These expansion 
coefficients are statistically independent of one another, meaning the probability of a 
given random error is the same as the probability of selecting the associated set of 
expansion coefficients.  To compute the expansion coefficient PDFs, KDE was used 
with a Gaussian kernel.  The PDFs allow for the sampling of synthetic random error 
DVFs.  To validate the model for all voxels lying within the three organs of interest, the 
distributions of vector displacements derived from the original sequence of training 
DVFs were compared to those derived from a much larger set of synthetic DVFs 
randomly sampled from the patient-specific PCA model.  This was done for all patients, 
and no significant differences between the vector distributions were found in any voxel.  
Patient-specific modeling has potential applications in VCTs, allowing researchers to 
create a full fractionation scheme of realistic daily anatomies from a smaller dataset.  An 
example of this model’s use in probabilistic planning was also given.63  
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5.2. Population PCA modeling 
In Chapter 3, the PCA technique was extended from patient-specific modeling to 
population modeling of the male pelvis.  To do this, a common reference coordinate 
system was needed.  In this thesis, I present one solution to the difficult problem of 
patient-to-patient registration, enabling the patient-specific systematic and random 
errors to be mapped to the common reference coordinate system.  Due to the difficulty 
of interpatient DIR, the systematic and random errors were mapped separately for each 
organ (prostate, bladder, and rectum) and stitched together in the reference coordinate 
system.  The inverse consistency error introduced by mapping patient’s systematic and 
random errors to and from the reference coordinate system was determined to be ≤ 0.1 
mm for most voxels within the three organs.  The well-known parameters of   and  , 
which are measurements of the systematic and random error distributions, were 
expanded to the 3D volume covering the entirety of the prostate, bladder, and rectum.  
These parameters were calculated for each organ voxel and for both bony-aligned and 
prostate centroid-aligned patient setups.  The centroid-aligned setup showed smaller 
(~2.5x) systematic and random errors within the prostate when compared to bony 
alignment.  The two setup approaches each had unique distributions of errors.  Each 
setup showed smaller systematic and random errors near the alignment points (bony 
anatomy and prostate centroids).    
PCA was used to successfully model the systematic and random errors in a 
population of prostate cancer patients.  A population systematic and random model 
used data from a population of patients to describe the magnitude and likelihood of a 
given deformation.  Separate models were created using the bony-aligned and prostate 
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centroid-aligned data.  For all models, the PCA reconstruction error was calculated as 
the error introduced by using a limited number of eigenmodes (eigenmodes 
representing ≥ 95% of the overall variance).  In the voxels within the prostate, the mean 
systematic and random errors were all near zero with standard deviations of ≤ 0.56 mm 
in all directions.  In order to test the model’s ability to represent systematic and random 
errors not included in the PCA training data, a leave-one-out study was performed.  
Each patient’s systematic and random errors were reconstructed using a PCA model 
constructed from data exclusively from other patients.  However, the standard deviation 
of the voxel differences between the PCA representations of the “left out” patient and 
the original systematic DVF was over 2 mm in the bladder anterior-posterior and left-
right directions.  These standard deviations were smaller for random errors, yet still over 
a millimeter in some directions.  The larger errors in the systematic error leave-one-out 
study indicate that a larger dataset may be necessary to model all modes of systematic 
tissue motion.  This work is the first time that both systematic and random tissue 
displacements have been modeled for the prostate patient population. 
5.3. Clinical application of the population model 
In Chapter 4, I used the population models described in Chapter 3 to create 
anisotropic PTV margins and tested their efficacy relative to conventional PTV margin 
recipes via a VCT framework.  For both bony- and centroid-aligned setups, synthetic 
systematic and random prostate DVFs were sampled from their respective PCA models.  
These DVFs were then summed to create a synthetic random instance of deformed 
central pelvic anatomy.  The interpatient registrations were used to transport each 
synthetic prostate DVF to the planning image of the patient and to deform the physician-
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drawn planning contours.  By averaging the set of bitmaps representing the synthetically 
deformed prostate contours, an organ occupancy map was eventually created.  For 
each patient, a PCA-based PTV was created by thresholding the occupancy map at the 
95% level.  IMRT treatment plans using the PCA-based PTV were then compared to 
plans created using clinically used PTVs.  For a bony-aligned setup, the clinically used 
PTV was created using the van Herk margin formula found in equation (14).  For 
centroid-aligned setup, the clinically used PTV was created using a 5 mm (3 mm 
posterior) expansion.  In bony-aligned setup, the PCA-based PTVs were found to give a 
mean 15.7% (range 10.3-23.2%) reduction in volume when compared with the van Herk 
margin PTV.  For centroid-aligned setup, the mean volume reduction was 27.1% (range 
20.8-37.4%).  Plans were applied to a synthetically generated treatment course (using 
methods outlined in Chapter 1) for each of the 19 patients in the dataset.  In the bony-
aligned setup, the PCA- and van Herk-based margin plans each successfully delivered, 
on average, the prescription dose to at least 97% the target.  The PCA margin plans 
exhibited significant decreases (0.8 - 2.7 Gy) in D50, D30, D20, and D5 to the bladder and 
the D50 to the rectum, while giving a significantly higher dose to the rectum D20 and D5 
(2.6 and 2.3 Gy, respectively).  In the centroid-aligned setup, each plan, on average, 
delivered the prescription dose to at least 97% of the target while significantly 
decreasing (1.8 – 6.8 Gy) all DVH endpoints investigated for the bladder and rectum, 
with the exception of the rectum’s D5, where no significant difference was observed.  No 
loss in target dose coverage was seen for any PTVs used in the VCT, implying that all 
were overly generous.  This is believed to be caused by extended dose falloff in areas 
surrounding the CTV. 
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5.4. Summary 
In summation, in this thesis, I outlined and validated a method for statistically 
modeling the organ motion of patients undergoing definitive radiation therapy.  The 
modeling was performed on an individual basis and then expanded to model the organ 
motion of the patient population.  A straightforward method was developed to apply the 
population modeling in radiation treatment planning to illustrate the clinical utility of 
population as wells as individual patient statistical PCA models.  Using the VCT 
framework, mixed results were found comparing the dosimetric effects of the model 
based treatment planning compared to traditional treatment planning for patients 
aligned on bony anatomy.  For the subtrial comparing clinically used and PCA-based 
PTVs for a simulated prostate centroid alignment, the dosimetric benefit of the PCA-
based PTV margin was more pronounced.   
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Appendix A:  Principal component analysis (PCA) 
PCA is a widely used technique in linear algebra that is designed to extract 
relevant trends and structure from large datasets.  It does so by taking data of a high 
dimensionality, and reducing it to a smaller group that encompasses the majority of the 
variability in the data.  This is done by performing an orthogonal transformation on the 
data so that the greatest variance by any projection lies along the first coordinate, the 
second greatest variance along the second, and so forth.  There are many ways to 
perform this analysis, but the one used in this research will be presented here. 
Input Data 
The formation of the data matrix is essential for a successful implementation of 
PCA.  Suppose we perform a single measurement of M  distinct variables and place 
them in a data vector, 1X  as shown below. 
 
1,1
1,2
1
1,M
x
x
x
       
X    (16) 
Now suppose that a measurement of these same variables is repeated J  times, each 
producing a vector similar to that in equation (16).  The data matrix to describe these 
measurements will now be defined as 
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  
1,1 2,1 ,1
1,2 2,2 ,2
1 2
1, 2, ,
J
J
J
M M J M
x x x
x x x
x x x
        
X X X X

    

  (17) 
PCA works on mean subtracted data, so the mean must be computed for each row to 
give the mean value matrix, X . 
 
1
1 J
i
iJ 
 X X   (18) 
The final data matrix operated on by the PCA is 
 1 2MS J     X X X X X X X   (19) 
Covariance Matrix 
The covariance between two random variables is a description of how these 
variables change together.  For the random scalar variables x  and y , the covariance, 
 ,x y , of these two is defined as 
        ,x y E x E x y E y        (20) 
where  E  is the expectation value.  Note that when x y , the covariance is 
equivalent to the variance.  For a group of variables, like those defined in equation (19), 
the M M  sample covariance matrix, Σ , is computed as follows 
 
1
1
T
MS MSJ
 Σ X X   (21) 
This matrix gives the covariance between each data point in the data matrix, MSX , in the 
non-diagonal locations and the variances along the diagonal.   
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Orthogonal Transformation 
PCA now requires that the covariance matrix, Σ , undergo an 
eigendecomposition.  Mathematically, this means that the linearly independent 
eigenvectors (also called eigenmodes), v , and the eigenvalues,  , are found that 
satisfy the well-known eigenvalue equation. 
 Σv v   (22) 
Because the covariance matrix is symmetric, the spectral theorem guarantees it to be 
diagonalizable, and therefore contains 1J   associated pairs of eigenvectors and 
eigenvalues.   
The eigenvalues give the relative importance of each eigenvector.  The fraction 
of the variability of the data that can be represented by the associated eigenvector is 
given by 
 1
1
i
Ji
i
i



    (23) 
The eigenvalue with the largest fraction is, by definition, the most-principal 
component, the second largest eigenvalue with the second most-principal component, 
and so forth.  Because of this, the eigenvectors are sorted in descending order by their 
associated eigenvalues.  Typically, only the first L eigenvectors that are needed to 
account for the specified minimum percentage of the spectral variance (generally 90 to 
95%) are kept.  The discarded eigenvectors are likely associated with noise in the 
measurements and not representative of any real data trends. 
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Data Reconstruction 
PCA can be viewed as optimally changing the basis representation of the data 
variability into orthogonal (statistically independent) modes of variation.  However, in 
most cases, the data must be transformed back into the original basis.  This is done 
with the Karhunen-Loève transform, which allows an arbitrary data vector, RX , to be 
reconstructed as a linear combination of the eigenvectors and scaling coefficients   
 
1
L
R i i
i
c

 X v X   (24) 
The scaling coefficients are found using the dot product of the eigenvectors and the 
data that is to be reconstructed. 
  i R ic  X X v   (25) 
This transform can be used to reconstruct the original input data or to model a separate 
measurement not included in the original d data.  If 1J L  , the original input data can 
be reconstructed with no loss of information.   
High Dimensional Data 
The method outlined above becomes cumbersome when M becomes large, due 
in part to the computationally intractable task of diagonalizing a large-scale M M  
covariance matrix, since M  is typically the number of voxels in a 3D image (about 107) 
for this study’s application.  Solutions to this problem have been proposed, such as the 
use of singular value decomposition (SVD), which acts directly on the data matrix, MSX   
and is computationally stable.  However, this work uses a well-known modification of the 
traditional PCA method described above, which is beneficial when J M .75  The 
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details of this method are outlined below.  First, equation (21) is substituted into 
equation (22) 
  1 1 TMS MSJ  X X v v   (26) 
Now multiply both sides by TMSX   
    1 1 T T TMS MS MS MSJ  X X X v X v   (27) 
And define 
T
MSu X v  
 
1
1
T
MS MSJ
 X X u u   (28) 
Here, it is easy to see that TMS MSX X  is the much smaller J J  matrix ( 19J   in this 
study), making the eigenvalue problem much simpler to solve.  Now multiply both sides 
by MSX . 
    1
1
T
MS MS MS MSJ
 X X X u X u   (29) 
Looking within the parenthesis, we see that MSX u  is an eigenvector for equation (26).  
Thus, once the eigenvectors, u , are found, the full 3D image eigenvectors, v , can be 
found by 
 MSv X u   (30) 
It is important to note that v  may not be properly normalized.  In the instance where u  is 
normalized, and extra factor of  
1
1J   is needed for proper normalization of v . 
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Abstract 
Purpose:  To create a statistical population-based model of systematic and random pelvic 
tissue motion in prostate cancer patients; extend the concepts of systematic and random error 
distributions (  and  , respectively) to three dimensions; and demonstrate that the model 
predicts the magnitude, direction, and probability of systematic and random tissue 
displacements over a 5-7 week course of treatment. 25 
Methods:  CT images from 19 patients, each with a single planning image and 8-13 fractional 
images, were used in this study. Patient-specific systematic and random tissue displacements 
were calculated using deformable image registration (DIR) for two different patient setups, a 
bony aligned setup and a prostate-centroid aligned setup.  These vectors were transported to a 
reference coordinate system using inter-patient displacement vector fields (DVFs) mapping 30 
each patient’s planning image to the reference image.  The error introduced by mapping to and 
from the reference image was quantified.  With all patient data in a common coordinate system, 
  and   were computed for each voxel within the prostate, bladder, and rectum.  Principal 
component analysis (PCA) was used to create a statistical model of systematic and random 
tissue displacements.  The PCA modeling error introduced by only including the principal 35 
components representing 95% of the data variance was investigated and reported.  A leave one 
out study was performed to investigate the PCA model’s ability to represent systematic and 
random tissue motion not included in the PCA training data.  Finally, a method for sampling 
synthetic deformations from the PCA models was developed, and organ occupancy maps were 
created and compared between bony and prostrate-centroid aligned patient setups. 40 
Results:  Mapping patient-specific systematic and random tissue errors to and from the 
reference coordinate system introduced an error of about 0.2 mm.  The magnitudes of   and 
  at the reference image prostrate centroid were 1.6 and 1.5 mm, respectively, for prostrate-
centroid aligned patient setup and 4.6 and 4.1 mm for bony aligned setup.  For the PCA 
modeling, 11 eigenmodes were needed to describe 95% of the data variance in the systematic 45 
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motion model, while 33 were needed to describe 95% of the variance in the random motion 
model.  Using the limited number of eigenmodes introduced modeling error in the original data 
of less than 1 mm.  In the leave one out study, systematic errors within the prostate, bladder, 
and rectum not included in the PCA model were reconstructed with absolute mean errors 
between 1 - 2 mm.  Random errors had absolute mean errors between 0.5 - 0.9 mm for each 50 
organ.   
Conclusions:  Systematic and random pelvic tissue positioning errors were modeled using a 
PCA statistical model to within an error of 1-2 mm.  The authors developed, implemented and 
validated a PCA-based technique to determine the principal modes of systematic and random 
organ deformation.  In the population under study, the prostate-centroid aligned technique 55 
reduced the   and   in the areas of clinical interest and gave greater certainty in prostate 
localization compared to bony alignment. 
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1. Introduction 
Organ motion has long since been a challenge across all anatomical sites in 
radiotherapy.  Hereafter, “organ motion” will refer to either the displacement or deformation of 
the anatomy of the treatment day from the planning anatomy.  The magnitudes of the motion 65 
have been extensively studied and reported for intrafraction motion, e.g. lung76-78 and  
pancreas79,80, as well as interfraction motion, e.g., pelvis1,79,81.  Each site presents different 
challenges and requires different motion-management strategies.   
It is often beneficial to separate interfraction organ motion into its systematic and random 
components.  A systematic targeting error is the discrepancy between the anatomy that is 70 
planned and the patient’s mean anatomy throughout their treatment. The daily residual motion 
after being corrected for by the systematic component is random targeting error.  It has become 
common practice to use online image-guided radiotherapy (IGRT) in order to reduce the effect 
of the motion on tumor targeting.  However, current deterministic corrections use only a rigid 
shift of the patient, which cannot account for the residual 3D aspects of the motion, such as soft 75 
tissue deformation.  The current practice for prostate cancer is daily rigid alignment based on 
implanted fiducials.  This still leaves residual systematic and random errors introduced by soft 
tissue deformation.  In most cases, organ rotations are not taken into consideration.  Organs at 
risk (OARs), such as the highly deformable rectum and bladder, are also not taken into account, 
even though their motion could cause higher toxicities than anticipated based on the planning 80 
image.    In lung cancer, tracking cycle-to-cycle variations around the mean is difficult and when 
technically feasible, is limited to translational isocenter position corrections. 
 When direct measurement and incorporation of each day’s organ motion into the plan of 
the day is not feasible, probabilistic treatment planning (PTP) may be an option. Rather than 
correcting for each instance of organ motion, from knowledge of the distribution of organ-motion 85 
errors, PTP endeavors to maximize the probability of achieving specified planning goals.  These 
goals vary, as does the complexity of the planning technique.  The simplest and most widely 
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used PTP method is the clinical target volume (CTV)-to-planning target volume (PTV) 
expansion margin.  To determine the necessary margin, several formulas have been proposed 
based on varying assumptions about the dose coverage to most patients in a population, 90 
including normality of the systematic and random error spatial distributions.  The most well-
known formula was proposed by van Herk, who sought to deliver 95% of the prescription as the 
minimum dose to the CTV for 90% of all patients.39  As input, this formula requires the 
distribution of systematic and random errors of the tumor centroid relative to the planning image 
for the patient population.  This formula is limited by its underlying assumptions, as it treats the 95 
tumor as a rigid body, and does not account for the deformable nature of the tumor and 
completely ignores OARs (organs at risk).  More advanced PTP methods have been developed 
to directly incorporate the probability of a given anatomical instance directly into plan 
optimization.56,82-84  These methods are only as good as their input model describing the 
statistics of the patient’s organ motion.  Currently, there are few fully 3D statistical models of 100 
organ motion that compute the probability of random and systematic instances of anatomy. 
 The goal of this paper is to address this void and to extend the concept of systematic 
and random error from a single tumor centroid to every voxel within the CTV, as well as the 
associated OARs in the male pelvis.  This avoids assumptions of the rigidity/non-rigidity of the 
organs.  This paper applies principal component analysis (PCA) modeling to deformable image 105 
registrations (DIR) in order to statistically model these anatomical systematic and random 
displacements throughout a patient’s treatment course.  DIR produces displacement vector 
fields (DVFs), which quantify the inter-fractional organ motion.  While others have used the PCA 
technique to investigate patient-specific random tissue displacements46,85 and even random 
displacements across a population49, this paper is the first to model both random and systematic 110 
error distributions for the prostate patient population. 
 In this paper, patient-specific systematic and random errors (as described by DVFs), are 
transported to a common coordinate system though inter-patient DIR.  With each patient’s data 
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in a common reference frame, PCA is used to model the principal modes of systematic and 
random organ motion. 115 
2. Methods 
2.1 Patient dataset 
Fan beam computed tomography (CT) images of the male pelvis collected at the 
Netherlands Cancer Institute (NKI) from 19N   patients undergoing definitive external beam 
radiotherapy for prostate cancer were used in this study.  All images were anonymized.  Each 120 
patient was imaged once before treatment and 8-13 times (median 11) throughout the course of 
treatment.   Let Ω ⊂ Թଷ denote the domain of a CT image. Denote ܫ௜,௞: Ω → Թ as the CT image 
of the ith patient and the kth fractional image were 1 i  N  and 0  i  Pi . By convention, k  0 
denotes the pretreatment CT image and Pi  denotes the number of fraction images of the i
th 
patient.   There were 210 fractional images in this dataset., The 3D prostate, bladder, and 125 
rectum were contoured by a single experienced radiation oncologist on each of these images.  
The cutoff for the superior boundary of the rectum was the inferior edge of the iliosacral joints.  
Protocols for data acquisition were previously reported by Deurloo.57 
For each patient, two different patient setups were investigated.  The first approach aligned 
all fractional images to the planning image by matching a set of bony landmarks.  The second 130 
approach aligned all fractional images to the planning image by aligning the prostate centroid in 
the fractional images to the prostate centroid in the planning image.  The prostrate centroid was 
calculated from physician-drawn contours of each image.  No rotations were considered in the 
initial patient alignment.   
2.2 Deformable image registration 135 
2.2.1 Intra-patient DIR 
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Define    , ,0 :Ω Ωi k i h  as the Eulerian transformation that maps the kth fractional image 
of the ith patient ܫ௜,௞ to the reference image ܫ௜,଴. Denote    , ,0 :Ω Ωi k i u  as the displacement 
vector field (DVF) associated with    , ,0i k ih  where 
            , ,0 , ,0  for i k i i k i   h x x u x x  (1) 140 
Deformable image registration (DIR) was used to determine the transformation.  This was 
done using the SICLE algorithm (small deformation, inverse consistent, linear elastic) using both 
grayscale and contour matching for the bladder, prostate, and rectum.58  SICLE’s objective 
function contains intensity matching, inverse consistency, and regularizing terms.  The intensity 
matching is done using a sum of squares differences using both CT intensities and contour 145 
information.  Contours were incorporated into the algorithm by converting each contour into a 
binary mask image.  The algorithm simultaneously searches for both forward and inverse DVFs 
relating the two input images and their associated contour masks.  The objective function 
contains terms penalizing inverse inconsistent registrations.  A linear elastic regularizing term is 
also included in the objective function.  The transformation is parameterized using a Fourier 150 
basis.  The weighting coefficients of the Fourier bases are the output parameters of SICLE.  The 
algorithm utilizes a multi-resolution approach, starting off minimizing the objective function on a 
coarse grid of the images and iteratively refining the parameters on a finer grid.  The resultant 
DVFs spanned the whole image with voxel sizes of approximately 1.8x1.8x0.3mm. The images 
were initially rigidly aligned using the bony anatomy.  The physician-drawn contours were used 155 
to validate this algorithm.  The output DVFs were used to deform the contours and the Dice 
similarity metric was used to compare the deformed contours with the physician drawn ground 
truth.  This was done for every transformation deforming a fractional to the planning image.  
Over all fractions and all patients, resultant Dice similarity indices for the prostate, bladder, and 
rectum were (mean±SD) 0.92±0.02, 0.95±0.03, and 0.89±0.03 respectively. 160 
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2.2.2 Inter-patient deformable registration and construction of a reference image 
Pooling data across patients to create a statistical model of DVF variability in a population 
of patients requires a common coordinate system.  This was achieved by deforming each 
patient’s reference image ܫ௜,଴ to a population reference image ܫ௥௘௙. In principle, the resulting 
inter-patient transformation  ,i k refh  can be used to transport intra-patient DVFs       ,0, ,0 ii k iu x  165 
derived from different patients onto the coordinate system of ܫ௥௘௙ where they can be indexed 
and compared to one another in a common coordinate system.    
Inter-patient registration of the pelvic anatomy is extremely challenging for most DIR 
algorithms.  This is due to many reasons including differences in anatomy, abutting organs in 
the source image may be separated in the target image or vice versa, and organs may slide 170 
against one another from one image to the next. The SICLE image registration algorithm 
assumes that two images can be registered using a continuous transformation parameterized 
by the 3D Fourier series. As a result, the SICLE algorithm performs poorly in regions where 
abutting organs separate or slide against one another.  In these instances, registrations using all 
organ segmentations simultaneously failed.  Consequently, we performed separate single-organ 175 
deformable registrations for the three central pelvic organs (bladder, prostate, and rectum) to 
allow for the most accurate registration for each organ.         
To derive Iref  (with support limited to the three central pelvic structures), SICLE contour 
driven registration was performed to register each patient’s planning contours to the 
corresponding contours of a preselected patient.  This preselected patient was chosen for its 180 
lack of abnormal anatomy (i.e. minimal bowel gas, average prostate size) upon visual 
inspection.  The organ-specific DVFs that map voxels from the preselected I p,0  to every other
Ii ,0 , i  p  were then averaged to calculate the mean organ-specific DVF.  The mean DVFs were 
then used to deformably map the central organs from I p,0  into Iref  , creating a stitched average 
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simulation image, consisting of binary images of the bladder, rectum, and prostate.  We then 185 
deformably registered each of the 19 patient’s central pelvic organs as contoured on planning 
images, one at a time, to the corresponding structures on Iref .  This yielded the transformations 
h i ,0 refbladder , h i ,0 refprostate , and h i ,0 refrectum , along with the inverse mappings  ,0
bladder
i refg ,  ,0
prostate
i refg , and 
 ,0
rectum
i refg .  These transformations were subsequently used to transfer systematic and random 
statistical information to and from the average reference patient, where the data can be pooled 190 
and compared. 
 
Figure 1.  The creation of the reference image.  Patient planning images are first registered to a single patient’s 
planning image, from which the reference image is then created using the mean deformation. 
2.3 Development of a statistical model of deformed anatomies 195 
2.3.1 Systematic and random anatomical deformations 
We assume that each patient’s DVF describing the mapping of a fractional anatomy to its 
planning anatomy,      ,0, ,0 ii k iu x , is the sum of systematic and random components,  ,0i iu x  
and      ,0, ,0 ii k iΔu x , respectively.  The systematic component is defined as the DVF which 
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maps each voxel from its planning image, Ii ,0  to its location, averaged over its positions in each 200 
daily treatment image, Ii ,k . 
 ui xi ,0   1Pi u i ,k  i ,0  xi ,0 k1
Pi   (2) 
Each patient has a single  ,0i iu x .  The day-to-day fluctuations of anatomical deformations 
about  ,0i iu x  are represented by      ,0, ,0 ii k iΔu x , which describes the k-th fraction offset of 
each voxel ,0ix  from the planning image in treatment fraction k from its mean location,  ,0i iu x , 205 
during the treatment course. 
              ,0 ,0 ,0, ,0 , ,0i i i ii k i i k i  Δu x u x u x   (3) 
For brevity,  ,0i iu x  and      ,0, ,0 ii k iΔu x , are hence referred to as “systematic DVF 
component” and “random DVF component,” respectively.  These quantities are 3D 
generalizations of the systematic and random setup error concepts utilized in the margin 210 
formula by van Herk.39 
2.3.2 Transport of patient-specific vector fields into reference coordinate system 
The systematic and random DVF components,  ,0i iu x  and      ,0, ,0 ii k iΔu x , which are 
functions of the patient-specific simulation-image coordinate systems, are transported organ-by-
organ to the reference coordinate system, refx , using the inter-patient DVFs,    ,0bladder refi refu x , 215 
   ,0prostate refi refu x , and    ,0rectum refi refu x .  This is done by treating the systematic and random 
components as vector-valued images and deforming their vector fields with the inter-patient 
DVF.   
       , ,0ref prostate prostatei ref i ref refi ref u x u x u x   (4) 
This is done for all organs and for the systematic and random components.   220 
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As described below, the resultant components were “stitched” together in the reference 
coordinate system to form a single systematic or random error, with support limited to the three 
pelvic structures.  The single-organ systematic or random error’s support was taken to be any 
voxels within the associated organ, plus a 1 cm margin around the organ.  The margin was 
necessary to avoid interpolation errors at the organ surfaces introduced when deforming the 225 
reference contours.  The stitching for the systematic and random errors is given mathematically 
below.  
  
 
 
 
,
, ,
,
if Rectum+1cm
if Bladder+1cm
if Prostate+1cm
rectum ref
i ref ref
union ref bladder ref
i ref i ref ref
prostate ref
i ref ref
   
u x x
u x u x x
u x x
  (5) 
and 
  
 
 
 
,
,
, ,
, ,
,
,
if Rectum+1cm
if Bladder+1cm
if Prostate+1cm
rectum ref
i j ref ref
union ref bladder ref
i j ref i j ref ref
prostate ref
i j ref ref
    
u x x
Δu x u x x
u x x
  (6) 230 
Volumes where these margins overlapped were handled using a prioritization.  The prostate 
took first priority, the bladder second, and the rectum third.  In all, there are N  different 
systematic errors and 
1
210
N
i
i
P

  random errors, all in the reference coordinate system. 
2.4 Inverse consistency 
In order for a population model to have value, information extracted from it in the reference 235 
coordinate system (e.g. randomly sampled DVFs or summary statistics) must be mapped back 
to a patient’s local coordinate system.  The process of mapping the systematic and random 
components to and from the reference coordinate system introduces error, due to the DVF 
stitching and the fact that inter-patient transformations are not exactly inverse consistent.  The 
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impact of these two factors was tested as a whole, and will be referred to subsequently as the 240 
“inverse consistency error”. 
In order to quantify inverse consistency error, the systematic and random errors were 
mapped to the reference frame, then immediately mapped back to the local patient’s frame, 
where they were compared with original. 
 
        
 
      
, ,
, ,0 ,0,0
,0 ,0 ,0,0
, ,
, ,0 ,0 ,0 ,0,0
,
for each , find corresponding ( )
( )
 where prostate, bladder, rectum,
o o o ref o patient
i IC i i ref i ii ref
o
i ref i iref i
o o ref o o patient
i IC i i i i i iref i
o l
i o



 
 
  

δ x g u x u x
x x u x x
δ x u u x x u x
u  or union and = patient or ref coordinate system l
  (7) 245 
where “organ” is a placeholder for the prostate, bladder, and rectum, as each organ is done 
separately.  To quantify inverse consistency error, the mean and standard deviation of 
 , ,0oi IC iδ x  was averaged over all voxels within the organ for each patient separately, and over 
the population of patients. 
2.5 Quantifying the statistics of systematic and random voxel displacements 250 
The systematic and random error components of the tissue displacement must be 
transported to the reference coordinate system in order to get a statistical characterization of the 
entire patient population.  The characterization is done by generalizing the well known concepts 
of group mean, systematic error ( ), and random error ( ), introduced by van Herk to model 
statistical fluctuations of setup error, to three dimensions.  255 
The group mean,  refM x , is defined as 
    ,
1
1 N union ref
ref i ref
iN 
 M x u x   (8) 
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Generalizing the classical definition of van Herk, which was limited to the GTV centroid, we 
define the systematic tissue displacement error,  refΣ x , as a function of location, refx , in the 
reference image, by 260 
       2,
1
1
1
N
union ref
ref i ref ref
iN 
  Σ x u x M x   (9) 
Similarly, the random error,  refσ x , is calculated as the root mean square over all patients of 
the standard deviation of each patient’s daily tissue displacements.  Mathematically, it is defined 
as 
     2,,
1 1
1 1
1
iPN
union ref
ref i k ref
i kiN P 
  σ x Δu x   (10) 265 
 
2.6 PCA for constructing probability density functions (PDFs) of deformed anatomies 
The goal of this statistical model is to quantify the amount of uncertainty in tissue 
displacements across a population of patients.  This knowledge is potentially useful when 
designing a plan resistant to such uncertainties for a patient whose individual tissue 270 
displacements are unknown a priori.  Equations (8)-(10), above, assume that each voxel moves 
independently of its neighbors.  Obviously, voxels within an organ move coherently, giving rise 
to significant voxel-to-voxel correlations.  The Fourier transformation parameterization and linear 
elastic regularization present in the DIR used in this work guarantee this correlation.  To 
incorporate these correlations, the statistics of systematic and random errors were modeled 275 
using the PCA technique in the reference coordinate system. Supposing there are L voxels in 
the image, we can define the 3L  N matrix of population mean-subtracted systematic data 
matrices are calculated as  
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   1 1 1, 1
1
( ) ( )
( ), , ( ), , ( )
( ) ( )
ref
N
sys sys
i i N
L N L
x x
x x
        
x
Δ Δ
D D Δ x Δ x Δ x
Δ Δ

   

  (11) 
where    ,1 1( ) union ref ref Δ x u x M x .  The columns of sysD  are the group-mean subtracted 280 
patient-specific systematic displacements, while the rows are mean-subtracted systematic 
displacements of a specific voxel.  The same is done to create the random data matrix, randD .  
From these, their respective covariance matrices are calculated.  The covariance matrix is a 
measure of each voxel’s correlation to the others, and is calculated by 
  1 1 Tsys sys sysN C D D   (12) 285 
Similarly, we can define the  13 N ii P L    matrix    , 1, , , 1, ,rand i j ref ij P i N    D Δu x    
and the corresponding covariance matrix 
  
1
1 Trand rand rand
N
i
i
P



C D D
 
 (13) 
PCA is an orthogonal transformation, or eigendecomposition, of the covariance matrix, which 
seeks to diagonalize the matrix.   290 
 
sys sys sys sys
l l l
rand rand rand rand
l l l




C v v
C v v
  (14) 
 and sys sysl l v denote the lth of N nonzero eigenvalues and eigenvectors, respectively. In practice, 
the 3 3L L  matrices are too large to invert.  Hence equations (12) and (13) are multiplied by 
    or T Tsys randD D   transforming the covariance matrix to easily invertible 19x19 or 212x212 
matrices and with 3 L  eigenvector matrices.75  The result of each decomposition is an 295 
orthonormal set of basis eigenvectors, syslv  and 
rand
lv , that satisfy the eigenvector equation (14).  
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In principle, any random or systematic deformed instance of 3D anatomy,  refu x , can be 
expressed as a linear combination of these eigenvectors and scalar expansion coefficients, lc .   
    
1
1 sysL sys
ref l l ref
l
c
N 
 u x v M x   (15) 
In equation (15), sysL  represents the number of eigenmodes necessary to account for 95% of 300 
the variance in the data.  Typically, sysL N , reducing the dimensionality of the problem.  The 
eigenvectors (or eigenmodes) are ordered so that the first principal component, with the largest 
l accounts for the most variance possible in the data.  The second mode is the orthogonal 
vector that accounts for the next largest contribution to variance, and so forth. 
2.7 PCA modeling error 305 
By using a limited number of eigenmodes, some amount of error is introduced when 
reconstructing the original set of systematic and random spatial distributions.  To quantify this 
error, equation (15) and its random counterpart was used to reconstruct each systematic and 
random DVF using sysL  or randL   eigenmodes.  In the refx coordinate system, each 
reconstructed displacement field was compared to the original DVF, and the arithmetic mean 310 
and standard deviation of the voxel-by-voxel differences calculated for each organ.  For each 
patient, the discrepancies were further averaged over the 8-13 random component DVFs 
associated with each patient.    
2.8 Leave one out study 
For the PCA model to be useful clinically, it must be able to accurately describe systematic 315 
and random displacement distributions from patients that were not part of the training set. 
Nineteen different systematic and random DVF PCA models were built, each using data from 18 
patients by excluding each patient in turn.  The scaling expansion coefficients required to 
approximate the patient’s systematic and random errors in equation (15) were calculated by  
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    sysl l ref refc   v u x M x      (16) 320 
Then, the systematic DVFs for the omitted patient were estimated using equation (15), with 
the random DVFs estimated similarly.  This process was repeated for the other patients, 
creating 19 different models in total, each created using data from the other patients.  
Differences between the DVFs for the 19 omitted patients as reconstructed by PCA and directly 
calculated by SICLE were evaluated separately for each organ in each patient.  The mean and 325 
standard deviation of the errors were reported. 
2.9 Randomly sampling PCA PDFs and organ occupancy maps 
A useful application of the PCA statistical models is the creation of organ occupancy maps.  
These maps show the probability of an organ of interest occupying each voxel in a patient’s 
simulation image, taking into account both random and systematic anatomy deformation.  To 330 
create these occupancy maps, samples of systematic and random DVFs must be randomly 
drawn from the PCA model and then added together in order to create a synthetic deformation.  
This is done by creating and sampling from a probability density function (PDF) of the expansion 
coefficients, lc , associated with each eigenvector in both the systematic and random 
displacement models.  The PDF is created from the histogram of eigenvalues (19 and 210 335 
values for systematic and random DVFs, respectively, for each eigenmode) by the well-known 
method of kernel density estimation.60,61  Practically, this is done by using equation (16) to 
compute the expansion coefficients, , 1, ,ilc i N   for each of the N DVFs in the training set.  All 
of the coefficients associated with a given eigenvector are grouped together and each is 
represented by a Gaussian kernel: 340 
    
2
22
1
1 exp
22
iN
l
l
i
c c
p c
bN b 
      
   (17) 
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where b is an adjustable bandwidth parameter set according to the recommendations in 
Silverman.62  A typical example is shown in Figure 2.  This is a well known technique for 
estimation of the underlying PDF when used in conjunction with PCA.86  This technique has 
been previously applied in the estimation of DIR uncertainties.59   345 
 
Figure 2.  An example of a PDF built through kernel density estimation (KDE).  The final PDF (dashed purple) is 
created through superposition of many Gaussian kernels taken from the training data coefficients.  This PDF 
corresponds to the first eigenmode associated with the prostrate-centroid aligned systematic displacements. 
It is simple and efficient to sample expansion coefficients to use in equation (15) for 350 
creating synthetic systematic and random tissue DVFs, which when added together, form a 
synthetic deformation of the anatomy.  This deformation is then used to deform the reference 
anatomy, yielding a possible anatomical instance.  This process is repeated 1000 times, and the 
deformed anatomies are then averaged for each voxel, giving the probability of a given organ 
occupying that voxel on a given treatment day.  This is done for both bony and prostrate-355 
centroid aligned setups, and the resultant occupancy maps were compared. 
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3. Results 
3.1 Inverse consistency 
The results of the inverse consistency on the systematic error are shown for each patient in 
Figure 3.  This shows the mean inverse consistency error,  , ,0organi IC iδ x  of the inter-patient 360 
transformations for transporting patient specific systematic error DVFs.  Table 1 gives the mean 
and standard deviations of the errors across all patients.  In all patients, the mean error is 0.2 
mm or less resulting in submillimeter discrepancies with standard deviations of 0.1 – 0.3 mm 
when averaged over patients.  This suggests that the lower limit of meaningful DVF error 
modeling is about 0.2 mm with the SICLE code.  365 
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Figure 3.  The inverse consistency error for the systematic error in the prostate (blue), bladder (red), and rectum 
(green) of each patient in the left-right (LR), anterior-posterior (AP), superior-inferior (SI) directions as well as the 
error magnitude.  The dot represents the voxel-by-voxel mean error within the organ with the error bars representing 
one standard deviation. 370 
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Table 1. Mean and standard deviation of the inverse consistency results for the population modeling of both 
systematic and random deformations in the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) 
directions. 
  LR (mm) AP (mm) SI (mm) 
Systematic 
Prostate 0.01±0.08 0.00±0.12 0.01±0.09 
Bladder 0.01±0.12 0.02±0.13 0.01±0.11 
Rectum -0.02±0.19 0.00±0.22 0.01±0.10 
Random 
Prostate 0.00±0.01 0.00±0.07 0.00±0.09 
Bladder 0.00±0.03 0.00±0.11 0.00±0.16 
Rectum 0.00±0.04 0.00±0.11 0.00±0.10 
 375 
3.2 Spatial distribution of systematic and random dispersion parameters 
The single-voxel group mean, M , and standard deviations, Σ  and σ of the population 
distribution of systematic and random voxel displacements as a function of  error maps are 
shown in Figure 4 when the prostate centroids on each day-of-treatment image set is assumed 
aligned with the simulation centroid.  At the prostate centroid, the magnitudes of the group 380 
mean, systematic error, and random errors are 0.4, 1.6, and 1.5 mm respectively.  One would 
expect these quantities to be approximately zero.  However, this work aligns on the prostate 
centroid, and due to asymmetric deformation of the prostate, one can expect that DIR will not 
necessarily map the day-of-treatment centroids onto the simulation image centroid.  These 
errors increase with increasing distance from the point of alignment, with standard deviations as 385 
large as 10 mm in the bladder base and near the rectal-sigmoid colon junction due to variations 
in bladder and rectal filling. 
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Figure 4.  Sagittal views of the population mean, M , systematic error standard deviation, Σ , and random error 
standard deviation , σ , in mm for the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions.  390 
The values shown here are for daily patient alignment of the prostate centroid.  The characterization maps are in the 
reference coordinate system, but overlaid on a sample patient anatomy to give a sense of location within the pelvis. 
 The results for the bony alignment setup are given in Figure 5.  At the prostate centroid, 
the group mean, systematic error standard deviation, and random error standard deviation 
magnitudes are 1.7, 4.6, and 4.1 mm respectively.  These are, as expected, larger than the 395 
corresponding values for the prostate centroid setup case.  Figure 5 shows a modest trend 
towards reduced tissue deformation near adjacent bony structures, although some large errors 
are evident, e.g., AP random tissue displacement in bladder neck near the pubic symphysis, 
indicating that distances between bladder and rectal surfaces proximal to bones varies 
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significantly. For the prostate, the largest uncertainty is the AP location of the prostate base, 400 
which has a  of about 8 mm.   
  LR AP SI 
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Figure 5. Sagittal views of the group mean, M  systematic error, Σ , and random error, σ , standard deviations in 
mm for the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions.  The values shown here are 
for daily online bony alignment.  These quantities are mapped in the reference coordinate system, but overlaid on a 
sample patient anatomy to give a sense of location within the pelvis. 405 
 
3.3 PCA modeling error 
The PCA modeling error is shown (see Figure 6 and Table 2) for only the online prostrate-
centroid alignment case.  In order to account for 95% of the variance in the data, 11sysL   and 
33randL  eigenmodes were needed.  Over all patients, the mean and standard deviations of the 410 
PCA reconstruction error for systematic and random displacements is given in Table 2.  The 
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mean PCA reconstruction errors were all near zero with standard deviations of approximately 
0.5 mm and exceed 1 mm only for a very small number (3.8% for systematic) voxels.  In 
general, PCA modeling errors are larger than inverse-consistency errors.  
 Systematic Random 
LR 
AP 
SI 
Figure 6:  Mean difference between PCA reconstructions and original systematic component DVF along each axis.  415 
For each patient, the dots represent the mean error and the error bars show the standard deviation.  The data shown 
here is for prostrate-centroid aligned data. 
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Table 2.  Mean and standard deviation of the PCA reconstruction error for both the systematic and random 
deformations in the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions, averaged over 420 
patients as well as voxels and daily treatment images for the case of prostrate-centroid alignment.  
  LR (mm) AP (mm) SI (mm) 
Systematic 
Prostate 0.00±0.33 0.00±0.54 0.00±0.33 
Bladder 0.00±0.51 0.00±0.50 0.00±0.40 
Rectum 0.00±0.82 0.00±0.78 0.00±0.46 
Random 
Prostate -0.01±0.21 0.00±0.36 -0.01±0.23 
Bladder 0.04±0.63 0.04±0.85 0.03±0.68 
Rectum -0.03±0.65 0.09±0.79 -0.03±0.48 
 
3.4 Leave one out study 
In order to reconstruct the systematic displacements, 19 PCA models were created for the 
leave one out study.  As with the PCA modeling error results, only the online prostrate-centroid 425 
alignment case is presented here, as results were similar for the bony alignment case.  For most 
PCA models, either 10-11 or 32-33 principal components, respectively, were necessary to 
account for 95% of the variance in the systematic and random displacement input data. The 
average error is quite small, but with significant patient-to-patient variability.  The largest mean 
errors (about 2 mm) are bladder and rectal systematic errors.  Leave one out errors are much 430 
smaller for the random displacements than those for the systematic, implying that a larger 
dataset might be necessary to fully describe the systematic variability in the pelvis. 
  
D Vile et al.: Population modeling of systematic and random tissue errors 
126 
 
 Systematic Random 
LR 
AP 
SI 
Figure 7:  Results of the leave one out study for both systematic and random displacements in the case of the online 
prostrate-centroid alignment case, for each of the “left-out” patients.  The arithmetic means and standard deviations 435 
over organ voxels between the actual DVF and that inferred from equations (16) and (15) are shown. 
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Table 3.  Mean and standard deviations of the PCA modeling errors evaluated over the 19 “left out” patients in the 
leave one out study for the online prostrate-centroid alignment protocol. The mean absolute error is given below the 440 
grand mean and standard deviations.   
  LR (mm) AP (mm) SI (mm) 
Systematic 
Prostate 0.01±0.81 
0.84 
-0.05±1.25 
1.42 
-0.03±0.87 
1.00 
Bladder -0.26±2.27 
1.19 
0.01±2.08 
1.18 
0.01±1.33 
0.97 
Rectum -0.05±1.22 
2.11 
0.12±1.31 
1.83 
-0.11±1.02 
1.31 
Random 
Prostate 0.00±0.71 
0.55 
0.00±0.87 
0.76 
0.00±0.58 
0.54 
Bladder 0.00±1.14 
0.67 
0.00±1.17 
0.72 
0.00±0.80 
0.52 
Rectum 0.00±0.89 
0.87 
0.00±0.94 
0.91 
0.00±0.68 
0.62 
 
3.5 Organ occupancy maps 
The organ occupancy maps were calculated for both the prostrate-centroid and bony 
aligned setup are presented in Figure 8.  Using prostrate-centroid alignment, the prostate’s 445 
position is known with much greater certainty.  The bony alignment shows variable uncertainty 
in the prostate’s position over 2 cm in the anterior and posterior directions, compared to 7 mm in 
the prostrate-centroid aligned patient. For the bladder and rectum in the prostrate-centroid 
aligned setup, the organ can be located with greater certainty in regions bordering the prostate, 
while the bony aligned setup has greater certainty in their location near bony anatomy. 450 
 Axial Sagittal Bony Aligned Centroid Aligned Bony Aligned Centroid Aligned 
Prostate 
 
Bladder 
 
Rectum 
 
Figure 8:  Organ occupancy maps for the prostate, bladder, and rectum for both bony and prostrate-centroid aligned setup.  The colormap corresponds to the 
probability of a given voxel containing the organ on a given day.  These are in the reference coordinate system and are overlaid on a sample patient for ease of 
viewing
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4. Discussion 
This paper generalizes the concept of systematic and random displacement errors to 
three-dimensional space by calculating them on a voxel by voxel basis.  Previously, clinical 
practice was limited to calculating these displacements and their statistical distributions at a 
single point, generally the prostate centroid or an implanted marker.   The assumption is that the 
prostate moves as a rigid body.  This assumption completely ignores tissue deformation.  This 
work shows general agreement with the literature on the values of   and   at the prostate 
centroid, as shown in Table 4 for a bony aligned setup.  However, our 3D calculation shows that 
these numbers are not consistent throughout the prostate, and can vary considerably near the 
prostate surface.  These differences can potentially create a geometric miss to certain portions 
of the prostate during the course of treatment.  This work also includes the motion patterns of 
the bladder and rectum. 
Table 4.  Comparison of this study’s   and   values at the prostate centroid with selected values previously 
reported in the literature.  All values are in mm and are for a bony aligned setup.  Abbreviations:  LR – left/right, AP 
– anterior/posterior, SI – superior/inferior. 
     
Study LR AP SI LR AP SI 
van Herk87 0.9 2.7 1.7 0.9 2.7 1.7 
Beltran81 0.9 3.5 3.0 1.2 2.8 2.0 
Current 
study 
0.9 4.0 2.4 1.2 2.5 3.3 
 
 While this study included 210 sets of random tissue displacements, only 19 systematic 
tissue displacements were available for this paper.  Obviously, our statistical model is limited by 
this input data in the types of deformations that it can represent.  A leave one out study was 
conducted to try to quantify the ability of the PCA models to correctly describe the systematic 
and random organ motion of patient’s not in the PCA training set.  This study suggested that the 
systematic organ motion could be accurately described to within about 1.5 mm.  This suggests 
that the 19 systematic error samples used in this study might be too small to fully model all 
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possible modes of systematic motion.  The random organ motion could be modeled to a much 
better accuracy.   
 Accurate inter- and intra-patient DIRs are necessary in building the statistical model.  
The intra-patient registrations were done using both grayscale and contour information of the 
fractional images.  These registrations were validated using a Dice metric.  Inter-patient 
registrations were a much more difficult process to deal with.  Using a similar process to the 
intra-patient registrations, some of our registrations failed to converge on a final DVF.  These 
were due to the large anatomical differences between the patients.  As the DIR algorithm used 
in this study cannot model DVF discontinuities due to use of Fourier series basis functions, we 
adopted an heuristic approach, i.e., independently registering the organs using only contour 
information.  This approach correctly modeled individual organ shape and relative positions to 
one another and the bony pelvis of each patient.  However, uncontoured structures, e.g., pelvic 
lymph nodes, vascular bundles, seminal vesicles, and pelvic bones, are not included.  Nor do 
our registrations have the benefit of matching soft-tissue features. This makes our results 
dependent on the regularization (linear-elastic constitutive law) of our DIR algorithm and its 
ability to deform the organs in a realistic manner.  For future work, a finite element based DIR 
would appear to be a better option, as it can produce DVFs with support limited to the organs of 
interest. 
 Inter-patient DIR is necessary in this work to transport DVFs in a patient’s coordinate 
system to the coordinate system of the reference patient.  This need to transport changes in a 
single patient to a reference patient or template is a current topic of study called “parallel 
transport”.88,89  The idea is to transport vectors along geodesics while retaining vector 
parallelism.  In the future, these methods could produce a better method for pooling the 
statistics in this study. 
 While not directly demonstrated in this work, our statistical model has several possible 
clinical applications for improving treatment.  PTP is perhaps the most important such 
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application. Conceptually, our PCA model is used to randomly select an ensemble of systematic 
and randomly deformed instances of a patient’s anatomy, enabling the optimizer to select the 
MLC leaf sequence that maximizes the fraction of deformed instances of anatomy meeting the 
treatment goals and constraints.56  In order to do this, some knowledge of the distribution of 
displacements must be known a priori.  Our statistical model gives detailed information about 
this population distribution over all voxels within the three organs of interest.   
 A more straightforward application of this work is construction of a patient PTV that 
represents a more optimal tradeoff between target coverage and normal tissue dose.  Currently, 
isotropic or pseudo-isotropic margins are used to create the PTV, many times based off of 
margin formulas.  Also, the van Herk formula cannot be directly applied to the prostrate-centroid 
alignment protocol, as the   and   parameters would be zero.  PCA population modeling can 
create anisotropic margins for any patient setup that would provide more coverage in areas of 
larger deformation and less coverage in areas of minimal deformation.  Synthetic systematic 
and random displacements could be sampled from our model, transferred to the patient’s 
planning image coordinate system, and used to deform their planning contours.  An organ 
occupancy diagram can be created for the prostate similar to those presented in this work.  This 
diagram could be thresholded (covering, for example, 95% of all anatomical variations), and this 
volume could be used as the PTV. 
5. Conclusion 
The purpose of this work was to create a statistical population model of systematic and 
random tissue motion. Patient-specific systematic and random displacements were transported 
to a reference coordinate system.  In this reference coordinate system, the traditional measures 
of systematic and random error distributions,   and  , were calculated for the prostate, 
bladder, and rectum on a voxel by voxel basis for bony and prostrate-centroid aligned patient 
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setups.  A PCA technique was implemented to determine the principal modes of systematic and 
random deformation.   
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